ANTI-INFLAMMATORY AND IMMUNE-MODULATING EFFECTS OF RICE CALLUS SUSPENSION CULTURE AND BLUEBERRY EXTRACT ON AN IN-VITRO INFLAMMATORY BOWEL DISEASE MODEL by Driscoll, Kyle Michael
Michigan Technological University 
Digital Commons @ Michigan Tech 
Dissertations, Master's Theses and Master's Reports 
2017 
ANTI-INFLAMMATORY AND IMMUNE-MODULATING EFFECTS OF 
RICE CALLUS SUSPENSION CULTURE AND BLUEBERRY EXTRACT 
ON AN IN-VITRO INFLAMMATORY BOWEL DISEASE MODEL 
Kyle Michael Driscoll 
Michigan Technological University, kmdrisco@mtu.edu 
Copyright 2017 Kyle Michael Driscoll 
Recommended Citation 
Driscoll, Kyle Michael, "ANTI-INFLAMMATORY AND IMMUNE-MODULATING EFFECTS OF RICE CALLUS 
SUSPENSION CULTURE AND BLUEBERRY EXTRACT ON AN IN-VITRO INFLAMMATORY BOWEL DISEASE 
MODEL", Open Access Dissertation, Michigan Technological University, 2017. 
https://digitalcommons.mtu.edu/etdr/497 
Follow this and additional works at: https://digitalcommons.mtu.edu/etdr 
 Part of the Alternative and Complementary Medicine Commons, Chemicals and Drugs Commons, and the 
Digestive System Diseases Commons 
ANTI-INFLAMMATORY AND IMMUNE-MODULATING EFFECTS OF RICE 
CALLUS SUSPENSION CULTURE AND BLUEBERRY EXTRACT ON AN IN-
VITRO INFLAMMATORY BOWEL DISEASE MODEL 
 
 
By 
Kyle M. Driscoll 
 
 
 
A DISSERTATION 
Submitted in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
In Biological Sciences 
 
MICHIGAN TECHNOLOGICAL UNIVERSITY 
2017 
 
© 2017 Kyle Driscoll 
  
This dissertation has been approved in partial fulfillment of the requirements for the 
Degree of DOCTOR OF PHILOSOPHY in Biological Sciences. 
 
Department of Biological Sciences 
 
  
 Dissertation Advisor: Rupali Datta 
 
 Dissertation Co-Advisor: Ramakrishna Wusirika 
 
 Committee Member: Aparna Deshpande 
 
 Committee Member: Tarun Dam 
  
 
 
 Department Chair: Chandrashekhar Joshi 
 
iii 
Table of Contents 
List of figures ..................................................................................................................... vi 
List of tables ...................................................................................................................... xii 
Preface.............................................................................................................................. xiii 
Acknowledgements .......................................................................................................... xiv 
Abstract ............................................................................................................................ xvi 
Introduction and Literature Review .....................................................................................1 
Chapter 1: Anti-Inflammatory Effects of Rice Callus Suspension Culture (RCSC) on 
Inflamed Colon Epithelial Cell Lines ..................................................................................7 
1.1 Abstract ..............................................................................................................8 
1.2 Introduction ........................................................................................................9 
1.3 Materials and Methods.....................................................................................13 
1.3.1 RCSC and Plant Medium ...................................................................13 
1.3.2 Human colon cell lines and culturing .................................................13 
1.3.3 Cell counting, freezing, and seeding protocol ....................................14 
1.3.4 Treatment with pro-inflammatory cytokine cocktail ..........................15 
1.3.5 Treatment of normal colon cell lines with RCSC and PM .................16 
1.3.6 Fluorescent Microscopy .....................................................................16 
1.3.7 Flow cytometry ...................................................................................17 
1.3.8 Gene expression assay ........................................................................17 
1.4 Results ..............................................................................................................18 
1.4.1 RCSC treatment reduced cytoplasmic ROS in InEpC, while 
increasing in NCM 356 and CCD 841 CoN, and enhanced nuclear ROS in all 
inflamed cell lines based on fluorescent microscopy analysis .......................19 
1.4.2 Flow cytometry analysis identified higher levels of nuclear and 
cytoplasmic ROS in inflamed NCM 356 and CCD 841 CoN cell lines treated 
with RCSC ......................................................................................................28 
1.4.3 RCSC treatment reduced the effect of inflammation on cell death in 
NCM 356 and CCD 841 CoN ........................................................................35 
1.4.4 Genes differentially regulated with RCSC treatment identified by 
quantitative real-time PCR .............................................................................39 
1.5 Discussion ........................................................................................................44 
1.6 Conclusion and future work .............................................................................48 
1.7 Acknowledgements ..........................................................................................49 
iv 
Chapter 2: Isolation of Bioactive Fractions from Rice Callus Suspension Culture (RCSC)51 
2.1 Abstract ...............................................................................................................52 
2.2 Introduction .........................................................................................................53 
2.3 Materials and methods ........................................................................................55 
2.3.1 Rice callus suspension culture ...............................................................55 
2.3.2 Preparation of RCSC for phytochemical analysis and thin layer 
chromatography (TLC) ...................................................................................56 
2.3.3 Column chromatography .......................................................................56 
2.3.4 High Performance Liquid Chromatography (HPLC) ............................56 
2.3.5 Human colon adenocarcinoma cell line SW620 culturing, passaging, 
and seeding .....................................................................................................57 
2.3.6 Normal human colon cell lines culturing, passaging, and seeding........58 
2.3.7 Treatment with pro-inflammatory cytokine cocktail .............................59 
2.3.8 in vitro cytotoxicity testing ....................................................................59 
2.4 Results .................................................................................................................61 
2.4.1 TLC plates identified spots in RCSC with different Rf values .............61 
2.4.2 Fractionation of RCSC with column chromatography and HPLC ........64 
2.4.3 RCSC and concentrates induced rapid cell death in human colon 
adenocarcinoma cell line SW620 ...................................................................71 
2.4.4 RCSC and fractions 10-18 significantly increased cell death in human 
colon adenocarcinoma cell line SW620 comparable to whole RCSC ...........74 
2.4.5 RCSC and concentrates mildly increased cell death in normal human 
colon cell line CCD 841 CoN .........................................................................77 
2.4.5 RCSC fractions 10-18 resulted in mild increases in cell death, but 
showed less toxicity than whole RCSC on the normal human colon cell line 
CCD 841 CoN ................................................................................................79 
2.4.6 RCSC fractions 10-18 increased nuclear and cytoplasmic ROS in the 
normal human colon cell line CCD 841 CoN ................................................80 
2.5 Discussion ...........................................................................................................82 
2.6 Conclusion and future directions ........................................................................86 
2.7 Acknowledgements .............................................................................................86 
Chapter 3: Anti-inflammatory Effects of Northern Highbush Blueberry Extract on Two 
Inflamed Colon Epithelial Cell Lines ................................................................................87 
3.1 Abstract ...............................................................................................................88 
3.2 Introduction .........................................................................................................89 
3.2.1 Inflammation and Inflammatory Bowel Disease (IBD) ........................89 
3.2.2 Anti-inflammatory effects of northern highbush blueberry extract 
polyphenols.....................................................................................................91 
3.3 Materials and methods ........................................................................................92 
v 
3.3.1 Human colon cell lines ..........................................................................92 
3.3.2 Cell counting, freezing, and seeding protocol .......................................92 
3.3.3 Phenolic rich blueberry extract ..............................................................93 
3.3.4 Treatment of normal human colon cell lines with pro-inflammatory 
cytokine cocktail and blueberry extract ..........................................................94 
3.3.5 Fluorescent microscopy .........................................................................94 
3.3.6 Flow cytometry ......................................................................................95 
3.4 Results .................................................................................................................95 
3.4.1 Blueberry extract significantly reduced nuclear and cytoplasmic ROS in 
inflamed human colon epithelial cells based on fluorescent microscopy ......96 
3.4.2 Blueberry extract significantly reduced nuclear and cytoplasmic ROS in 
inflamed colon epithelial cells based on flow cytometry analysis ...............103 
3.4.3 Bluberry Exract Significantly reduced cell death following treatment 
with the pro-inflammatory cytokine cocktail based on flow cytometry 
analysis 111 
3.5 Discussion .........................................................................................................113 
3.6 Conclusion and future work ..............................................................................117 
3.7 Acknowledgements ...........................................................................................117 
References ........................................................................................................................118 
Conclusion .......................................................................................................................127 
Future Directions .............................................................................................................129 
 
vi 
List of figures 
Figure 1.1: RCSC modulates nuclear ROS in InEpC cell line..........................................21 
Figure 1.2: Summary data of RCSC nuclear ROS in InEpC cell line ..............................21 
Figure 1.3: RCSC decreases cytoplasmic generated ROS in InEpC cell line...................22 
Figure 1.4: Summary data of RCSC cytoplasmic ROS in InEpC cell line........................22 
Figure 1.5: RCSC increases nuclear ROS in NCM 356 cell line.......................................23 
Figure 1.6: Summary data of RCSC nuclear ROS in NCM 356 cell line..........................24 
Figure 1.7: RCSC increases cytoplasmic ROS in NCM 356 cell line...............................25 
Figure 1.8: Summary data of RCSC cytoplasmic ROS in NCM 356 cell line..................25 
Figure 1.9: RCSC increases nuclear ROS in CCD 841 CoN cell line...............................26 
Figure 1.10: Summary data of RCSC nuclear ROS in CCD 841 CoN cell line................27 
Figure 1.11: RCSC increases cytoplasmic ROS in CCD 841 CoN cell line.....................27 
Figure 1.12: Summary data of RCSC cytoplasmic ROS in CCD 841 CoN cell line........28 
Figure 1.13: RCSC increases nuclear ROS in NCM 356 cell line as analyzed by flow 
cytometry...........................................................................................................................30 
vii 
Figure 1.14: Summary data of RCSC nuclear ROS in NCM 356 cell line for flow 
cytometry...........................................................................................................................30 
Figure 1.15: RCSC increases cytoplasmic ROS in NCM 356 as analyzed by flow 
cytometry...........................................................................................................................31 
Figure 1.16: Summary data of RCSC cytoplasmic ROS in NCM 356 cell line for flow 
cytometry...........................................................................................................................31 
Figure 1.17: RCSC increases nuclear ROS in CCD 841 CoN cell line as analyzed by flow 
cytometry...........................................................................................................................33 
Figure 1.18: Summary data of RCSC nuclear ROS in CCD 841 CoN cell line for flow 
cytometry...........................................................................................................................34 
Figure 1.19: RCSC mildly increases cytoplasmic ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry...............................................................................................35 
Figure 1.20: Summary data of RCSC cytoplasmic ROS in CCD 841 CoN cell line for 
flow cytometry...................................................................................................................36 
Figure 1.21: RCSC reduced the effects of the pro-inflammatory cytokine cocktail on cell 
death in NCM 356 cell line as analyzed by flow cytometry..............................................37 
Figure 1.22: Summary data of reduced cell death by RCSC in NCM 356 cell line..........38 
Figure 1.23: RCSC reduced the effects of the pro-inflammatory cytokine cocktail on cell 
death in CCD 841 CoN cell line as analyzed by flow cytometry......................................39 
viii 
Figure 1.24: Summary data of reduced cell death by RCSC in CCD 841 CoN................39 
Figure 1.25: Heat map evaluating selected genes from immune response fast plate........41 
Figure 2.1: Images of RCSC and methanol extract...........................................................64 
Figure 2.2: HPLC chromatogram of the 25 fractions collected via column 
chromatography.................................................................................................................71 
Figure 2.3: HPLC chromatogram of fractions 10-18.........................................................72 
Figure 2.4: RCSC induces rapid cell death on the human colon adenocarcinoma cell line 
SW620 as analyzed by fluorescent microscopy.................................................................73 
Figure 2.5: RCSC, concentrates, and fractions 10-18 rapidly induce cell death following 
30-minute treatments.........................................................................................................75 
Figure 2.6: RCSC fractions 10-18 induced rapid cell death in the human colon 
adenocarcinoma cell line SW620 as analyzed by fluorescent microscopy........................77 
Figure 2.7: RCSC, concentrates, and fractions 10-18 had minimal toxicity towards the 
normal colon cell line CCD 841 CoN................................................................................79 
Figure 2.8: RCSC fractions 10-18 increased nuclear ROS in CCD 841 CoN similarly to 
whole RCSC as analyzed by flow cytometer.....................................................................81 
Figure 2.9: RCSC fractions 10-18 increased cytoplasmic ROS in CCD 841 CoN similarly 
to whole RCSC as analyzed by flow cytometer.................................................................83 
ix 
Figure 3.1: Phenolic rich blueberry extract greatly reduced nuclear ROS in NCM 356 cell 
line....................................................................................................................................101 
Figure 3.2: Summary data of blueberry extract nuclear ROS in NCM 356 cell line.......101 
Figure 3.3: Phenolic rich blueberry extract greatly reduced cytoplasmic ROS in NCM 
356 cell line......................................................................................................................102 
Figure 3.4: Summary data of blueberry extract cytoplasmic ROS in NCM 356 cell 
line....................................................................................................................................103 
Figure 3.5: Phenolic rich blueberry extract reduced nuclear condensation in NCM 356 
cell line.............................................................................................................................104 
Figure 3.6: Summary data of blueberry extract nuclear condensation in NCM 356 cell 
line....................................................................................................................................104 
Figure 3.7: Phenolic rich blueberry extract greatly reduced nuclear ROS in CCD 841 
CoN cell line....................................................................................................................105 
Figure 3.8: Summary data of blueberry extract nuclear ROS in CCD 841 CoN.............105 
Figure 3.9: Phenolic rich blueberry extract greatly reduced cytoplasmic ROS in CCD 841 
CoN cell line. ..................................................................................................................106 
Figure 3.10: Summary data of blueberry extract cytoplasmic ROS in CCD 841 CoN cell 
line....................................................................................................................................107 
x 
Figure 3.11: Blueberry extract decreases nuclear ROS in NCM 356 cell line as analyzed 
by flow cytometry............................................................................................................109 
Figure 3.12: Summary data of blueberry nuclear ROS in NCM 356 as analyzed by flow 
cytometry.........................................................................................................................109 
Figure 3.13: Blueberry extract decreases cytoplasmic ROS in NCM 356 cell line as 
analyzed by flow cytometry.............................................................................................110 
Figure 3.14: Summary data of blueberry cytoplasmic ROS in NCM 356 as analyzed by 
flow cytometry.................................................................................................................111 
Figure 3.15: Blueberry extract decreases nuclear and cytoplasmic ROS in NCM 356 cell 
line as analyzed by flow cytometry.................................................................................111 
Figure 3.16: Blueberry extract decreases nuclear ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry.............................................................................................112 
Figure 3.17: Summary data of blueberry nuclear ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry.............................................................................................113 
Figure 3.18: Blueberry extract decreases cytoplasmic ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry.............................................................................................114 
Figure 3.19: Summary data of blueberry cytoplasmic ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry.............................................................................................114 
xi 
Figure 3.20: Blueberry extract reduced the effects of the pro-inflammatory cytokine 
cocktail on cell death in CCD 841 CoN cell line.............................................................116 
Figure 3.21: Summary data of reduced cell death by blueberry extract on CCD 841 
CoN..................................................................................................................................116 
 
xii 
List of tables 
Table 1.1: Differentially regulated genes in RCSC vs. inflammatory control...................41 
Table 1.2: Differentially regulated genes in RCSC vs. plant medium control..................41 
Table 1.3: Differentially regulated genes in RCSC vs inflammatory control in CCD 841 
CoN....................................................................................................................................42 
Table 1.4: Differentially regulated genes in RCSC vs. inflammation and PM controls....43 
Table 1.5: Differentially regulated genes in NCM356 and CCD 841 CoN when treated 
with RCSC versus both inflammation and PM controls....................................................44 
 
 
 
 
 
 
 
xiii 
Preface 
My contributions to chapters 1 and 3 include the entirety of data collection with 
assistance in data analysis from Andrew D. Chapp.  HPLC data was collected with 
assistance from Zhimin Song. All data was collected in Dr. Ramakrishna Wusirika’s, Dr. 
Zhiying Shan, and Dr. Rupali Datta’s laboratories. I wrote the initial drafts with revisions 
made by Dr. Ramakrishna Wusirika to create the final product. Chapter 2 was developed 
by Dr. Ramakrishna Wusirika and Dr. Aparna Deshpande. My contributions include the 
entirety of data collection with assistance in data analysis from Andrew D. Chapp. I 
wrote the initial drafts, with revisions made by Dr. Ramakrishna Wusirika to create the 
final product. RCSC was made by a previous student, Dr. Surendar Reddy Dhadi. Initial 
training in experimental techniques was provided by Dr. Aparna Deshpande and Dr. 
Ramakrishna Wusirika. Most of the work was supported by a grant from the National 
Institute of Food and Agriculture, U.S. Department of Agriculture to Dr. Aparna 
Deshpande, Dr. Rupali Datta and Dr. Ramakrishna Wusirika.  
 
xiv 
Acknowledgements 
 First and foremost I would like to thank Les Cook, and Dr. Mike and Dr. Susan 
Skochelak for the generous financial gift, which has helped me tremendously along the 
way. I would like to also the biological sciences department for the support and funding I 
have received. 
 I would like to express my sincerest gratitude to my advisors, co-advisors and 
committee memebers; Dr. Ramakrishna Wusirika, Dr. Aparna Deshpande, Dr. Rupali 
Datta, and Dr. Tarun Dam whom have helped immensely to shape who I am today, 
beginning with my undergraduate career to where I am now. Without their continuing 
support, patience, understanding and immense knowledge from near and afar, I would not 
have accomplished what I have, nor would this dissertation be complete.  
 I would like to thank the helpful staff members of the department; Jeff Lewin, 
Patricia Asselin and Emily Betterly for their patience and understandings in times of 
distress and aiding in making things easier at Michigan Tech.  
 A special thanks goes to Dr. Qing-Hui Chen and Dr. Zhiying Shan for the vast 
amount of support in all areas of my research as well as with financial help.  
 I would especially like to thank my fellow graduate students and friends Andrew 
Chapp, Andrew Kennedy, Dr. Li Chen, Dr. Komal Raja, Jeffrey Kiiskila, Zichen Qian, 
Zhimen Song, and any other names I may have forgotten for the continual support and 
xv 
intuitive conversations along the way. The friendships I have made here will last a 
lifetime.  
Lastly, I owe a huge debt of gratitude to my parents Timothy and Catherine 
Driscoll who allowed me to realize my own potential, whom have been endlessly patient, 
supportive, and loving. They have helped shaped me in ways words cannot explain, and 
I’m wholeheartedly thankful for that.  
 
  
xvi 
Abstract 
Rice Callus Suspension Culture (RCSC) has been shown to exhibit potent 
anticancer activity in vitro. In this study we aimed to investigate the anti-inflammatory 
and immune-modulating properties of RCSC on three inflamed normal colon epithelial 
cell lines, InEpC, NCM 356, and CCD 841 CoN. As a comparative, we additionally 
analyzed the anti-inflammatory effects of Highbush blueberries on two inflamed colon 
cell cultures, NCM 356 and CCD 841 CoN. Furthermore, we sought to characterize the 
bioactive compounds in RCSC responsible for anti-cancer, anti-inflammatory, and 
immune-modulating effects. This work will be an essential starting point for 
understanding and identifying possible bioactive compounds in the fight against 
inflammatory bowel disease (IBD) and various cancers. 
 Fluorescent microscopy, flow cytometry, and quantitative polymerase chain 
reaction (qPCR) were performed, coupled with various bioassays, such as nuclear and 
cytoplasmic reactive oxygen species scavenging capabilities, propidium iodide cell 
viability assay, and gene microarrays to identify immunological gene targets. In doing so 
both RCSC and Highbush blueberry extracts were quantified for their anti-inflammatory 
and immune-modulating functions. 
 Finally, several organic solvents and techniques were utilized to identify possible 
bioactive compounds present in RCSC, Rotor evaporation, centri-vaped, column 
chromatography, thin layer chromatography (TLC), and high performance liquid 
chromatography (HPLC). Because of monetary and time restrictions we were unable to 
xvii 
identify the single responsible bioactive compound, if the case, however we were able to 
identify bioactive fractions consisting of eight compounds with anti-cancer and anti-
inflammatory properties with great similarities to the whole RCSC. This will serve as a 
starting point for characterization of the bioactive compound(s) 
 
1 
Introduction and Literature Review 
Plant secondary metabolites 
Plants for centuries have produced a wide variety of chemicals that do not 
primarily participate in growth and development of an organism1. These compounds, 
termed secondary metabolites, are distinctly distributed among a wide range of 
taxonomic groups, and contribute immensely to the overall fitness of an organism1,2.  
Additionally, they exhibit a broad range of biological activity, such as antibacterial, 
antifungal, antiviral, anti-inflammatory and anti-cancerous among others1-3. 
During 1981-2010, the Food and Drug Administration reported 34% of new small 
molecules approved were natural products and/or derivatives4. Furthermore, more than 
60% of chemotherapy and infectious disease drugs are from natural products. Their 
classification falls into three distinct classes, based on the route of synthesis: terpenoids, 
alkaloids, and phenylpropanoids and allied phenolic compounds1,2,5,6. Some examples 
include the terpenoid forskolin that is used to treat glaucoma, the anticancer drug 
vinblastine, the alkaloid morphine synthesized by Friedrich Serturner in 1806, and 
campthothecin, another anticancer drug, among a plethora of others1.  
Each class of secondary metabolites consists of distinct chemical structures, 
however extensive variations do exist. Terpenoids are classified based on a repetitive 
fusion of branched five-carbon isoprene units1. The term “isoprene” comes from the final 
product of thermal degradation of terpenoids resulting in the isoprene gas1. Terpenoids 
are the largest and most diverse class of natural products with 64,000 known 
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compounds1,7. The diversity in terpenoids structure and function has elicited great interest 
in possible medicinal and commercial uses7. 
Alkaloids have classically been defined as biologically active, nitrogenous 
containing compounds derived from plants1. After roughly 200 years of research, the 
definition has been changed to encompass a greater diversity of compounds. First, not all 
alkaloids are biologically active, second alkaloids, are found in animals and other taxa, 
and finally not all alkaloids contain a nitrogenous atom1. Alkaloids, like the third and 
final class of natural products (yet to be described) can be derived from amino acids, 
and/or purines, and/or a derivation of terpenoids, and/or acetate precursor with a 
nitrogenous heterocyclic ring. To this day, a single underlying defining characteristic of 
the term “alkaloids” is still unknown8. In saying this, around 30,000 compounds have 
been described as alkaloids8. These compounds have had a great influence on modern 
medicine, the most well known prescription alkaloid being the antitussive and analgesic, 
codeine. Additionally, alkaloids in recent times have had great influence in politics. The 
most well known example being the opium war between China and Great Britain in the 
years 1839-18591. 
Phenylpropanoids and allied phenolic compounds account for roughly 40% of 
circulating atmospheric carbon1. These compounds are characterized as metabolites, 
which are aromatic, and contain one or more acidic hydroxyl groups attached to a phenyl 
ring1. Phenolics are another broad category of bioactive compounds mainly derived from 
the phenylpropanoid and phenylpropanoid acetate pathway, which utilizes the aromatic 
amino acids phenylalanine and tyrosine1.  Additionally, an alternative metabolic process, 
3 
the shikimate pathway, generates copolymers utilizing the derived gallic and ellagic 
acids1. Several metabolites derived from these pathways are termed “flavonoids” which 
are comprised of over 4500 compounds1. Furthermore, flavonoids have been cited to 
exhibit anti-inflammatory, antiviral, antioxidant, and antineoplastic properties9. Some 
examples include quercetin which inhibits the cyclooxygenase pathway, and Hesperidin 
and Diosmin which significantly inhibit prostaglandin synthesis, acting as potent 
inflammatory mediators9. 
Plant exudates 
Plant exudates are compounds secreted by the roots of plants to modulate the 
rhizosphere, the root system and surrounding area10. This includes ions, inorganic acids, 
amino acids, organic acids, sugars, phenolic compound, as well as a vast array of 
secondary metabolites10. These compounds aid in maintaining the symbiosis between 
microorganisms and plants as well as preserving the overall fitness of the plant10.  
Recently much work has focused on generating bioactive compounds from in 
vitro plant exudates. There are several benefits to utilizing plant exudates versus organic 
extractions in that percent yield can be much higher then in the parent plant11. For 
example, rosmarinic acid from Coleus blumei cell culture was nine fold higher then from 
the whole plant. Additionally, extractions from exudates are simple compared to whole 
plant tissue, reducing possible production costs of bioactive compounds11.  
In utilizing in vitro plant exudates from rice callus, termed as rice callus 
suspension culture (RCSC), our research group identified bioactive compounds with 
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potent anticancer properties, which upon further investigation showed selectivity towards 
transformed cell lines with minimal toxicity towards normal cells in vitro12,13.  
Specifically, RCSC was a potent anticancer agent against colon adenocarcinoma and lung 
cancer cell lines. Because of this, we aimed to investigate if RCSC possessed anti-
inflammatory properties in an in vitro inflammatory bowel disease model. 
Inflammatory bowel disease (IBD) 
 Inflammatory bowel disease consists of two main disorders: Crohns disease (CD) 
and ulcerative colitis (UC)14-17. Roughly 1 million individuals in the United States have 
IBD, with an annual diagnosis of 30,000 individuals14. The age of onset for IBD is a 
bimodal distribution with the majority of cases occurring between the ages of 15-30 years 
and between 50-70 years14,15. Symptoms include diarrhea, abdominal cramping, anemia, 
weight loss and fatigue18. There is currently no cure; therefore treatment is dependent on 
symptom control, minimizing complications both transient and chronic, and improving 
quality of life17-19. While both disorders are characterized as chronic with relapsing 
inflammation of the intestinal epithelium, distinct pathologies do exist14-16. 
Crohns disease is characterized by patchy transmural inflammation, with “skip 
lesions”16. Pathologically, Crohns disease contains non-caseating granulomas with 
macrophage aggregates18. It most commonly affects the terminal ileum, with early 
symptoms appearing over Peyer’s patches, however any part of the gastrointestinal tract 
may be affected18. Ulcerative colitis is characterized by continual diffused mucosal 
inflammation that extends from the rectum to the proximal colon16,18. Histologically, 
5 
abscesses and large amounts of neutrophils are present within the lamina propria and the 
crypts18. Furthermore, several genetic and chemical concoctions are present. Employment 
of genome wide searches within the past decade or so have been highly successful in 
identifying genetic loci in IBD. Nucleotide Binding Oligomerization Domain Containing 
2 (NOD2) has strongly been implicated in the development of Crohn’s disease. 
Additionally, several genes responsible for epithelial barrier function seem to be major 
contributing factors in the pathogenesis of IBD, for example, N-cadherin mutant, Muc2, 
and ABCB1, among several others18. This coupled with increased cytokine production 
such as TNF-α, interleukin class molecules such as IL2 and IL23, and NF-κB seem to 
promote a chronically inflamed environment18. Moreover, this environment is amplified 
by the invasiveness of pathogenic bacteria. In trying to phagocytize and induce 
autophagy on infected cells, the “leaky gut” allows the bacterial toxins to further initiate 
the innate and adaptive immune responses further facilitating the chronic inflammatory 
cycle18. 
 Current treatment options revolve around the management of symptoms, and 
more recently immunotherapy based treatments. IBD manifests with a multitude of 
symptoms, which are largely due to the massive amounts of cytokines and chemokines 
released by the immune system. This information enabled researchers to target and create 
anti-antibodies. Initially, anti-inflammatory cytokines were targeted; specifically IL-10, 
IL-11, and IFNβ, however, the results were disappointing20. A breakthrough came with a 
neutralizing antibody targeting TNF, infliximab. In patients with Crohns disease the 
results were clinically astounding, major improvements were seen in the inflamed 
6 
tissues20. In patients with ulcerative colitis, similar results were obtained, which started 
the foundational treatment for patients with IBD20. While it seemed as if we had an 
understanding of the biochemical processes at work, similar anti-neutralizing antibodies, 
such as IFN-γ, did not shown any marked improvements, in some cases symptoms were 
exasperated20. 
Finally, while much progress has been made in treating IBD, there is still no cure. 
Additionally, several other drugs are still needed to control symptoms, such as 
corticosteroids and aminosalicylates among several others21. Aminosalicylates are of 
natural origin and there is a need to continue to utilize plants to search for compounds 
that can aid in the treatment of inflammatory diseases, such as IBD. In vitro generation of 
with unlimited plant secondary metabolites through callus suspension cultures exhibiting 
such effects, can prove to be important both economically and treatment efficiency. Fruit 
extracts, such as blueberries, also serve as important sources of biochemically active 
secondary metabolites. These in conjunction with current treatments might provide 
additional relief for the millions affected with IBD.   
7 
Chapter 1: Anti-Inflammatory Effects of Rice Callus 
Suspension Culture (RCSC) on Inflamed Colon 
Epithelial Cell Lines 
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1.1 Abstract 
Rice Callus Suspension Culture (RCSC) has been shown to exhibit potent 
anticancer activity in colon, renal, breast, and lung cancer cell lines. Here, we 
investigated the anti-inflammatory potential of RCSC on three inflamed normal 
colon epithelial cell lines, InEpC, NCM 356, and CCD 841 CoN. Cells were treated 
with a pro-inflammatory cytokine cocktail for 24 hours, followed by RCSC 
treatment at varying dilutions for 24-96 hours. Real time imaging utilizing cell 
viability and reactive oxygen species assays were performed. Fluorescent 
microscopy of InEpC treated with 1:5 dilution of RCSC for 24 hours showed drastic 
decrease in cytoplasmic reactive oxygen species (ROS), while mild increase was 
observed in nuclear generated ROS. NCM 356 treated with 1:40 dilution of RCSC 
for 48 hours showed minor increase in cytoplasmic generated ROS, while drastic 
increase was observed in nuclear generated ROS. CCD 841 CoN at a 1:40 dilution of 
RCSC for 48 hours revealed increase in nuclear generated ROS and decrease in 
cytoplasmic generated ROS. Flow cytometry analysis of propidium iodide staining 
was suggestive of decreased cell death in RCSC treated groups in both NCM 356 
and CCD 841 CoN. Several changes in gene expression were observed in NCM 356 
cell line with five genes upregulated and ten genes downregulated following 48-hour 
treatment with RCSC versus inflammatory control. Gene expression analysis on 
CCD 841 CoN cell line identified nine genes upregulated and 15 genes 
downregulated in RCSC treated versus inflammatory control.  Our studies suggest 
that RCSC can serve as a novel anti-inflammatory agent for the gastrointestinal 
tract. 
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1.2 Introduction 
  The human diet consists of a plethora of chemicals, which can have significant 
impact on the health and overall fecundity of a population. Plants have notoriously 
produced a wide variety of chemicals, which have been used for therapeutic purposes 
dating as far back as 1400BC to this day1,22. Today, they are regarded as the single most 
promising factor in drug discovery22.  Recently, within the last decade or so, between the 
years 2005 to 2007, thirteen drugs were approved which were naturally derived and of 
those thirteen, five represented newly discovered classes of drugs: peptide exenatides and 
ziconotides22. Since March 2008, we have seen a 30% decrease in the development of 
natural products, due to the seemingly disadvantageous nature of extraction, complex 
chemistry, apparent slow effects, as well as intellectual property rights22,23. Nevertheless, 
the wide therapeutic potential of natural products with minimal side effects has forced 
researchers to take a second look at them24. 
The bioactivity of natural products comes from a unique class of compounds 
termed “secondary metabolites”25-27. Secondary metabolites are small in size and 
produced by virtually all organisms in response to biotic and abiotic stress26. Although 
several health benefits that have been reported through dietary consumption or 
supplementation, the mechanisms by which these unique compounds act are poorly 
understood26,28,29. While other bioactive compounds do exist, such as saponins, 
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glycosides and others, plant secondary metabolites are divided into three major classes: 
terpenoids, alkaloids and phenylpropanoids and allied phenolic compounds1,5.   
 Terpenoids consist of a five-carbon precursor, isopentenyl diphosphate, which is 
capable of undergoing extensive structural modifications1,30. Terpenoids are present in 
large amount in plants and are structurally diverse class of secondary metabolites, which 
are involved in a wide range of biological functions. For example, cinnamon oil has 
shown antimicrobial activity against Pseudomonas aeruginosa. Additionally, camphor, 
menthol, and pyrethrins are all examples of terpenes which act as insecticides30. 
Alkaloids consist of one or more nitrogenous atoms and are derived mainly from L-
amino acids such as tryptophan, tyrosine, phenylalanine, lysine, and arginine1.  Alkaloids 
can further be divided into true alkaloids, which are found in 20% of all plant species and 
contain nitrogenous atoms in heterocyclic rings, and pseudoalkaloids which are not 
derived from amino acids, but still contain nitrogenous atoms31. These metabolites have 
over a 3000-year history of medicinal use, from the opioid morphine, and the 
antiarrhythmic aimaline, to the anticholinergic atropine1. Phenylpropanoids and allied 
phenolic compounds consist of metabolites, which are formed through the shikimate, 
malonate acetate pathway, and/or the phenylpropanoid and phenylpropanoid acetate 
pathway1. The shikimate pathway, in a series of seven metabolic steps, begins with the 
condensation of phosphoenolpyruvate and erythrose-4-phosphate to yield 3-deoxy-D-
arabino-heptulosonate 7-phophate (DAHP) and inorganic phosphate6. In the second 
reaction, a phosphate is eliminated from DAHP which yields 3-dehydroquinate (DHQ), 
followed by dehydration to give 3-dehydroshikimate (DHS)6. DHS is then reduced to 
11 
form shikimate, which is then phosphorylated by shikimate kinase to form shikimate 3-
phosphate6. From shikimate 3-phosphate, PEP is condensed along with shikimate 3-
phosphate to yield 5-enolpyruvylshikimate 3-phophate and inorganic phosphate6. In the 
final step, 5-enolpyruvylshikimate 3-phosphate, a phosphate is removed yielding 
chorismate6. From chorismate, three aromatic amino acids are formed, phenylalanine, 
tyrosine, and tryptophan. These three amino acids are then used in the synthesis of 
several proteins, as well as extensive synthesis of plant secondary metabolites1,6. The 
most basic examples derived from this pathway are the hydroxycinnamic acids, which 
consist of the basic C6C3 phenylpropane skeleton. The more complex compounds 
include flavonoids, isoflavonoids, and stilbenes, which are formed through the 
condensation of the phenylpropane backbone6.  
Current focus has shifted to in vitro generation of plant secondary metabolites 
through plant exudates. One such example is plant callus which has generated interest 
because of its nature of production (in vitro) compared to whole plant tissues11. 
Additionally, callus generation has several benefits compared to whole plants such as 
large scale generation of secondary metabolites without the need for growing plants in 
fields as well as ease of isolation and purification of products11.  Callus cultures tend to 
be equally effective as leaf extracts as shown in case of A. marmelos callus culture which 
was as effective in management of diabetes as leaf extract32. Callus is a mass of somatic 
undifferentiated totipotent cells whose suspension culture has been reported to show 
anticancer activity on multiple cancerous cell lines, with minimal effects on normal 
cells12,13.  
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Chronic inflammation is tightly linked with carcinogenesis. Individuals diagnosed 
with inflammatory bowel disease (IBD) or chronic ulcerative colitis, have a 10 to 40 fold 
increased risk in developing colorectal cancer33. Our current understanding on this 
transformation from a normal cell population to a neoplastic growth begins with transient 
exposure to biotic and abiotic stressors, which cause an immune response and release of a 
plethora of chemicals ranging from cytokines and chemokines to free radicals created 
through oxidative phosphorylation34,35. This release results in adaptive responses, 
stimulation of apoptosis and angiogenesis as well as induction of pre-neoplastic 
mutations34. While this transient response is a necessity for normal survival and function 
of the individual, chronic exposure leads to often-permanent neoplastic changes such as 
increased cell proliferation, oncogene activation, and mutagenesis34. These changes can 
eventually result in the formation of adenomatous polyps, and ultimately malignant 
adenocarcinomas34. Our current aim is to investigate the effects of rice callus suspension 
culture (RCSC) on three inflamed colon epithelial cell lines: InEpC, NCM 356 and CCD 
841 CoN and to mimic the inflammatory conditions of inflammatory bowel disease (IBD) 
by the pro-inflammatory cytokines: interlukin 1 beta (IL-1β), tumor necrosis factor alpha 
(TNF-α), interferon gamma (IFN-ϒ), and lipopolysaccharide (LPS). 
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1.3 Materials and Methods 
Corning® 96 well flat clear bottom polystyrene TC-treated micro plates, VWR® 
disposable serological pipets, polystyrene 5ml, 10ml, and 25ml VWR® SuperClear™ 
ultra-high performance centrifuge tubes were used.  
1.3.1 RCSC and Plant Medium 
 Plant Medium (PM) was made by supplementing Murashige and Skoog (MS) 
Medium (PhytoTechnology) with casamino acids, proline, and sucrose. The resulting 
mixture was dissolved in deionized water and autoclaved at 125°C for 20 min. The 
cooled mixture was further supplemented with Chu’s N6 vitamins (PhytoTechnology) 
and 2,4 dichlorophenoxyacetic acid (2,4D). 
Rice calli were produced from the seeds of Oryza sativa cultivar Nipponbare 
grown on solid MS medium with 2,4-dichlorophenoxyacetic acid (2,4-D) and Chu’s N6 
vitamins (PhytoTechnology Lab) at 28°C as described by Deshpande et al17. The calli 
were incubated in the sterile liquid plant medium for three weeks. During this incubation 
period, compounds were secreted into the medium. RCSC was then centrifuged at 10,000 
rpm for 10 min at 4°C for purification and removal of debris followed by absorbance 
readings between 240 nm and 300 nm using Nanodrop. The supernatant was filter 
sterilized and aseptically aliquoted into 50mL sterile culture tubes and stored at -20°C. 
1.3.2 Human colon cell lines and culturing 
 NCM 356 was obtained and licensed for three years from INCELL (San Antonio, 
TX). Cells were cultured and maintained in INCELL’s M300A with 10% fetal bovine 
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serum (FBS) at 37°C with 5% CO2 as per manufacturer’s recommendation. CCD 841 
CoN (ATCC® CRL-1790™) was obtained from ATCC (Manassas, VA) and cultured in 
Eagle’s minimum essential medium (EMEM, ATCC® 30-2003) with 10% FBS at 37°C 
with 5% CO2. InEpC (Clonetics™) normal human intestinal epithelial cell system was 
purchased from Lonza and maintained with SmGM™-2 BulletKit™ which includes 
supplements and growth factors, insulin, hFGF-B, hEGF, FBS and 
gentamicin/amphotericin-B. Penicillin-Streptomycin-Amphotericin B solution (ATCC® 
PCS-999-002) was purchased from ATCC. 
1.3.3 Cell counting, freezing, and seeding protocol 
Cell counting was done following the general trypan blue cell exclusion assay 
using a hemocytometer. Cells were initially collected from a monolayer using trypsin-
EDTA, centrifuged and then re-suspended in appropriate cell culture medium. From 
there, 25μl of cells were added to 475μl of cell culture medium to generate a diluted 1:20 
ratio of cells to medium. 50μl of the 1:20 dilution was then added to 10μl of the trypan 
blue stain. Finally, 10μl was utilized for cell counting on the hemocytometer. Cells were 
counted utilizing the following formula: Number of cells/mL = (X) * (20) * (1.2) * 104, 
where X = average number of cells in four squares, 20 = first dilution factor, and 1.2  = 
second dilution factor. Cells were then seeded in 6, 12, 24, or 96 well plates at the 
required cell density and incubated for 24 hours at 37°C, 5% CO2.  
 Cell freezing protocol for CCD 841 CoN was performed by detaching the cell 
monolayer using 3-4ml of trypsin-EDTA for 5-15 minutes, followed by addition of 6-8ml 
of cell culture medium to inactivate trypsin. The cells were then transferred into 50ml 
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conical tubes and centrifuged at 125 x g for 5-10 minutes as per manufacturer 
recommendation. The cell pellet was then re-suspended in complete growth medium and 
5% DMSO. A stepwise reduction in temperature was employed for cell freezing, first -
20°C for 24 hours, then -80°C for an additional 24 hours, and finally liquid nitrogen for 
long-term storage. 
NCM 356 cell line has a heterogeneous population. The floating cells and 
medium was collected and transferred to 15ml or 50ml conical tubes. The cells were then 
washed with calcium and magnesium free phosphate buffered saline (PBS) and kept in a 
separate 15ml or 50ml tube. Cells were then centrifuged at 500 x g for 5-10 minutes and 
re-suspended in 50-75% complete culture medium and the magnesium/calcium free PBS. 
Next, 2ml of trypsin-EDTA was added to the monolayer and incubated at 37°C for 5-10 
minutes, followed by the addition of complete growth medium to neutralize the trypsin. 
Cells were then pooled for counting and seeding purposes. Cells were cryopreserved in 
INCELL’s CPZ™ at a 1:1 ratio to M300A. The standard stepwise freezing process was 
used as stated above. 
1.3.4 Treatment with pro-inflammatory cytokine cocktail 
In order to stimulate an inflammatory response in vitro, cells were treated with a 
pro-inflammatory cytokine cocktail consisting of TNF-α (100ng/ml, Sigma), IL-1β 
(100ng/ml, Sigma), LPS (10μg/ml, Sigma), and IFN-γ (5μg/ml, Sigma) suspended in 
PBS, for 0-24 hours prior to any RCSC or PM treatment. 
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1.3.5 Treatment of normal colon cell lines with RCSC and PM 
When the cells reached a confluence of 70-90%, they were trypsinized, and 
seeded in 6, 12, 24, or 96 well plates at 25,000 cells per/ml for fluorescent microscopy, 
and 50,000-100,000 cells/ml for flow cytometry. Following 24 hour treatment with the 
pro-inflammatory cytokine cocktail, the cells were treated with varying dilutions of 
RCSC and PM, 1:5, 1:10, 1:20, 1:40, 1:80, to determine the lowest effective dose. Four 
time points were used: 24, 48, 72, and 96 hours.  
1.3.6 Fluorescent Microscopy 
NCM 356, CCD 841, and InEpC were cultured as per manufacturers’ 
recommendations. Cells were seeded in triplicates in appropriate medium supplemented 
with 3% heat-inactivated FBS at 25,000 cells per milliliter. Cells were visualized using 
Zeiss inverted fluorescent microscope following treatment for 24 hours with pro-
inflammatory cytokine cocktail and 24-96 hours with RCSC or plant medium, stains for 
cell viability and oxidative stress. Propidium iodide (ThermoFisher Scientific) was used 
to assay cell viability while CellROX® Green Reagent and CellROX® Orange Reagent 
were used to detect nuclear and cytoplasmic oxidative stress, respectively. Because of the 
limited number of cells with InEpC, only nuclear and cytoplasmic reactive oxygen 
species assays were performed. Cell fluorescence was quantified utilizing Image J 
software. Calculated total cell fluorescence (CTCF) = Integrated Density – (Area of 
selected cell X Mean fluorescence of background readings). Statistical significance was 
determined utilizing t-test, and 2-way ANOVA with Tukey’s post hoc test for pairwise 
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comparison with values represented as mean±SEM (standard error of the mean) and 
results were considered significant at p<0.05. 
1.3.7 Flow cytometry 
NCM 356 and CCD 841 CoN were seeded in 6 well Nunc™ cell culture treated 
dishes (Thermo Scientific), at a density ≥1x106 cells per milliliter, for 24 hours at 37°C 
with 5% CO2. Cells were then treated with an inflammatory cocktail consisting of TNF-α, 
IL-1β, LPS, and IFN-γ for an additional 24 hours prior to RCSC treatment. Following 24-
hour inflammatory cocktail treatment, cells were treated with RCSC or PM for 48 hours 
at 1:40 dilution (0.5mg/ml). Following the above treatment, cells were assayed with 
propidium iodide, or ROS to determine the effects of inflammation, PM, and RCSC on 
cell death. Data was analyzed utilizing percentages above or below control levels. T-test 
and 2-way ANOVA with Tukey’s post hoc test for pairwise comparison was utilized with 
values represented as mean±SEM and the results were considered to be significant at 
p<0.05. 
1.3.8 Gene expression assay 
NCM 356 and CCD 841 CoN were grown until they were 70-90% confluent. The 
cells were trypsinized, collected and seeded in triplicates in six well plates at 50,000 
cells/ml with 3% heat-inactivated FBS in the appropriate medium. Cells were allowed 
24-hour adjustment period prior to any treatment. Cells were then treated for 24 hours 
with pro-inflammatory cytokine cocktail prior to 24-96 hours of RCSC or PM treatments. 
RNA extraction was performed using Qiagen RNeasy® Mini Kit. Total RNA was 
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quantified using NanoDrop spectrophotometer. Equal amount of RNA was used for 
cDNA synthesis using Superscript® VILO cDNA synthesis kit. TaqMan® Universal 
Master Mix II with UNG were used for all gene expression assays.  
 Four, 96-well TaqMan® Arrays for human immune response were used for each 
cell line. Three housekeeping genes were tested; glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase 1 (HPRT1), and beta-
glucuronidase (GUSB). The other 92 genes are implicated in immune function, more 
specifically, cell surface receptors, cell cycle and protein kinases, oxidoreductases, signal 
transduction, stress response, transcription factors, chemokines and cytokines along with 
their receptors. 
 
1.4 Results 
  In order to quantitatively and qualitatively determine the effects of RCSC on 
three epithelial cell lines, we employed fluorescent microscopy and flow cytometry to 
determine free radical scavenging capabilities, as well propidium iodide for cell viability 
determination. 
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1.4.1 RCSC treatment reduced cytoplasmic ROS in InEpC, while 
increasing in NCM 356 and CCD 841 CoN, and enhanced nuclear 
ROS in all inflamed cell lines based on fluorescent microscopy 
analysis 
 InEpC treatment with CellROX® green nuclear ROS reagent revealed minor 
increase in RCSC treated versus inflammation control (Figure 1.1 and 1.2, p<0.05). 
InEpC cells treated with CellROX® orange probe revealed significant decrease in 
cytoplasmic ROS following treatment with RCSC at 1:40 dilution for 48 hours (Figure 
1.3 and 1.4, p<0.05). In most cases, treatment with the pro-inflammatory cytokine 
cocktail 24 hours prior to treatment resulted in higher nuclear and cytoplasmic ROS 
compared to control.  
   
   
Figure 1.1: RCSC modulates nuclear ROS in InEpC cell line. InEpC cells with 
CellROX® green nuclear ROS staining were treated for 24 hours with the pro-
A. B. 
C. D. 
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inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium or RCSC. 
(A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 
RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
 
Figure 1.2: Summary data of RCSC nuclear ROS in InEpC cell line. Quantification 
of CellROX® green nuclear ROS staining on InEpC cell line using Image J software. *= 
indicates significance vs. non treated control, &= indicates significance vs. inflammatory 
control. Results analyzed utilizing one way ANOVA with Tukeys test (n=5, p<0.05). 
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Figure 1.3: RCSC decreases cytoplasmic generated ROS in InEpC cell line. InEpC 
cells with CellROX® orange cytoplasmic ROS staining were treated for 24 hours with 
the pro-inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium or 
RCSC. (A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 
1:40 RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
 
Figure 1.4: Summary data of RCSC cytoplasmic ROS in InEpC cell line. 
Quantification of CellROX® green nuclear ROS staining on InEpC cell line using Image 
J software. *= indicates significance vs. non treated control, &= indicates significance vs. 
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inflammatory control, #= indicates significance vs. plant medium control. Results 
analyzed utilizing one way ANOVA with Tukeys test (n=5, p<0.05). 
NCM 356 (Figure 1.5 and 1.6, p<0.05) and CCD 841 CoN (Figure 1.9 and 1.10, 
p<0.05) treatment with CellROX® green nuclear ROS probe showed significant increase 
(p<0.05) in fluorescent intensity following treatment with RCSC at 1:40 dilution for 48 
hours, while treatment with CellROX® orange cytoplasmic probe again revealed 
significant increase in NCM 356 (Figure 1.7 and 1.8, p<0.05), and marginal increase in 
CCD 841 CoN (Figure 1.11 and 1.12) fluorescent intensity. 
   
   
Figure 1.5: RCSC increases nuclear ROS in NCM 356 cell line. NCM 356 cells with 
CellROX® green nuclear ROS staining were treated for 24 hours with the pro-
inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium or RCSC. 
(A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 
A. B. 
C. D. 
23 
RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
 
Figure 1.6: Summary data of RCSC nuclear ROS in NCM 356 cell line. 
Quantification of CellROX® green nuclear ROS staining on NCM 356 cell line using 
Image J software. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
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Figure 1.7: RCSC increases cytoplasmic ROS in NCM 356 cell line. NCM 356 cells 
with CellROX® orange cytoplasmic ROS staining were treated for 24 hours with the pro-
inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium or RCSC. 
(A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 
RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
  
Figure 1.8: Summary data of RCSC cytoplasmic ROS in NCM 356 cell line. 
Quantification of CellROX® orange cytoplasmic ROS staining on NCM 356 cell line 
using Image J software. *= indicates significance vs. non treated control, &= indicates 
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significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (n=5, p<0.05). 
   
   
Figure 1.9: RCSC increases nuclear ROS in CCD 841 CoN cell line. CCD 841 CoN 
cells with CellROX® green nuclear ROS staining were treated for 24 hours with the pro-
inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium or RCSC. 
(A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 
RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
A. B. 
C. D. 
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Figure 1.10: Summary data of RCSC nuclear ROS in CCD 841 CoN cell line. 
Quantification of CellROX® green nuclear ROS staining on NCM 356 cell line using 
Image J software. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (n=5, p<0.05). 
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Figure 1.11: RCSC increases cytoplasmic ROS in CCD 841 CoN cell line. CCD 841 
CoN cells with CellROX® orange cytoplasmic ROS staining were treated for 24 hours 
with the pro-inflammatory cytokine cocktail, followed by a 1:40 dilution of plant medium 
or RCSC. (A) Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 
1:40 RCSC. Images were taken at 20x magnification using a Zeiss inverted fluorescent 
microscope. 
  
Figure 1.12: Summary data of RCSC cytoplasmic ROS in CCD 841 CoN cell line. 
Quantification of CellROX® orange cytoplasmic ROS staining on NCM 356 cell line 
using Image J software. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (n=5, p<0.05). 
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1.4.2 Flow cytometry analysis identified higher levels of nuclear and 
cytoplasmic ROS in inflamed NCM 356 and CCD 841 CoN cell lines 
treated with RCSC 
NCM 356 overall morphology, as analyzed by flow cytometer, indicated increase 
in cell viability and forward scatter. Both forward scatter (FSC-A) and side scatter (SSC-
A) are dependent on the direction of light scattered by the cell. Forward scatter is able to 
distinguish between cell size and shape, whereas side scatter is able to detect internal 
complexity and granularity. NCM 356 treated with CellROX® green reagent following 
48 hour RCSC treatment revealed significant increase in nuclear generated reactive 
oxygen species compared to control, inflammation, and plant medium with 4.2%, 8.2%, 
30.3% of cells above baseline, versus 61.4% in RCSC treatment group under FL1 (Figure 
1.13 and 1.14, p<0.05). Treatment with CellROX® orange cytoplasmic ROS probe, 
following the same conditions as above, revealed higher number of cells fluorescing 
above baseline, in RCSC treated groups compared to controls. Control, inflammation, 
plant medium and RCSC with 4.6%, 11.5%, 14% and 40.4% cells, respectively, above 
the base line were observed (Figure 1.15 and 1.16, p<0.05). 
    
A. B. 
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Figure 1.13: RCSC increases nuclear ROS in NCM 356 cell line as analyzed by flow 
cytometry. NCM 356 cells were analyzed for ROS with CellROX® green nuclear stain 
following 24 hour treatment with the pro inflammatory cytokine cocktail and an 
additional 48 hours with a 1:40 diulution of RCSC or plant medium. (A) Control (B) 
Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 RCSC. Cells were 
analyzed using an BD Accuri™ C6 flow cytometer.  
  
Figure 1.14: Summary data of RCSC nuclear ROS in NCM 356 cell line for flow 
cytometry. Quantification of CellROX® green nuclear ROS staining on NCM 356 cell 
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line. *= indicates significance vs. non treated control, &= indicates significance vs. 
inflammatory control, #= indicates significance vs plant medium control. Results 
analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
    
    
Figure 1.15: RCSC increases cytoplasmic ROS in NCM 356 cell line as analyzed by 
flow cytometry. NCM 356 cells were analyzed for ROS with CellROX® orange 
cytoplasmic stain following 24 hour treatment with the pro inflammatory cytokine 
cocktail and an additional 48 hours with a 1:40 diulution of RCSC or plant medium. (A) 
Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 RCSC. 
Cells were analyzed using an BD Accuri™ C6 flow cytometer.  
A. B. 
C. D. 
31 
  
Figure 1.16: Summary data for RCSC cytoplasmic ROS in NCM 356 cell line for 
flow cytometry. Quantification of CellROX® orange cytoplasmic ROS staining on 
NCM 356 cell line. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
CCD 841 CoN treated with CellROX® green ROS assay displayed increase under 
FL1, with control, inflammation, plant medium, and RCSC treatments at 6.8%, 8.8%, 
8.7% and 32.5% fluorescent intensity, respectively above the base line (Figure 1.17 and 
1.18, p<0.05). Slight increase following treatment with CellROX® orange cytoplasmic 
ROS probe was observed by flow cytometer analysis with control at 3.9, inflammation 
and plant medium at 4.6% and 6.5%, respectively, and RCSC at 9.6% of total population 
under FL3 (Figure 1.19 and 1.20, p<0.05).  
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Figure 1.17: RCSC increases nuclear ROS in CCD 841 CoN cell line as analyzed by 
flow cytometry. CCD 841 CoN cells were analyzed for ROS with CellROX® green 
nuclear stain following 24 hour treatment with the pro inflammatory cytokine cocktail 
and an additional 48 hours with a 1:40 diulution of RCSC or plant medium. (A) Control 
(B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 RCSC (E) Merged 
A-D. Cells were analyzed using an BD Accuri™ C6 flow cytometer.  
   
Figure 1.18: Summary data of RCSC nuclear ROS in CCD 841 CoN. Quantification 
of CellROX® green nuclear ROS staining on CCD 841 CoN cell line. *= indicates 
significance vs. non treated control, &= indicates significance vs. inflammatory control, 
#= indicates significance vs plant medium control. Results analyzed utilizing one way 
ANOVA with Tukeys test (p<0.05). 
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Figure 1.19: RCSC mildly increases cytoplasmic ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry. CCD 841 CoN were analyzed for ROS with CellROX® 
orange cytoplasmic stain following 24 hour treatment with the pro inflammatory cytokine 
cocktail and an additional 48 hours with a 1:40 diulution of RCSC or plant medium. (A) 
Control (B) Inflammatory control (C) 1:40 Plant medium control and (D) 1:40 RCSC. 
Cells were analyzed using an BD Accuri™ C6 flow cytometer.  
A. B. 
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Figure 1.20: Summary data of RCSC cytoplasmic ROS in CCD 841 CoN cell line for 
flow cytometry. Quantification of CellROX® orange cytoplasmic ROS staining on CCD 
841 CoN cell line. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs plant medium control. 
Results analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
1.4.3 RCSC treatment reduced the effect of inflammation on cell death in 
NCM 356 and CCD 841 CoN 
 NCM 356 treated with the pro-inflammatory cytokine cocktail for 24 hours 
followed by 48-hour treatment of RCSC at 1:40 dilution showed significant increase in 
cell viability following staining with propidium iodide, when the samples were analyzed 
with FL3 (Figure 1.21 and 1.22, p<0.05). Control revealed 96.9% viable cells, compared 
with 24.9% and 16.4% in inflammatory and PM controls, respectively, followed by 
54.6% viable cells in RCSC treated group. This is suggestive of RCSC reducing cytokine 
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induced cell death. Following the same conditions as above, for CCD 841 CoN, RCSC 
increased cell survivability to 89.5% versus inflammation and plant medium at 79.5% 
and 85.5%, respectively (Figure 1.23 and 1.24). 
      
    
Figure 1.21: RCSC reduced the effect of the pro-inflammatory cytokine cocktail on 
cell death in NCM 356 cells as analyzed by flow cytometry. NCM 356 cells were 
analyzed for cell death using propidium iodide cell viability assay following 24-hour 
treatment with the pro-inflammatory cytokine cocktail and 48 hours of a 1:40 dilution of 
RCSC or plant medium. Results analyzed utilizing one-way ANOVA with Tukeys test, 
p<0.05. Analyzed under fluorescent laser three (FL3, 670nm filter). 
B. A. 
C. D. 
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Figure 1.22: Summary data of reduced cell death by RCSC in NCM 356 cell line 
Quantification of propidium iodide cell viability assay on NCM 356 cells. *= indicates 
significance vs. non treated control, &= indicates significance vs. inflammatory control, 
#= indicates significance vs plant medium control. Results analyzed utilizing one way 
ANOVA with Tukeys test (p<0.05). 
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Figure 1.23: RCSC reduced the effect of the pro-inflammatory cytokine cocktail on 
cell death in CCD 841 CoN cells as analyzed by flow cytometry. CCD 841 CoN cells 
were analyzed for cell death using propidium iodide cell viability assay following 24-
hour treatment with the pro-inflammatory cytokine cocktail and 48 hours of a 1:40 
dilution of RCSC or plant medium. Results analyzed utilizing one-way ANOVA with 
Tukeys test, p<0.05. Analyzed under fluorescent laser three (FL3, 670nm filter). 
  
Figure 1.24: Summary data of reduced cell death by RCSC in CCD 841 CoN. 
Quantification of propidium iodide cell viability assay on CCD 841 CoN cells. *= 
CCD 841 PI
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indicates significance vs. non treated control, &= indicates significance vs. inflammatory 
control, #= indicates significance vs plant medium control. Results analyzed utilizing one 
way ANOVA with Tukeys test (p<0.05). 
1.4.4 Genes differentially regulated with RCSC treatment identified by 
quantitative real-time PCR 
Several changes in gene expression (Figure 1.25) were observed in NCM 356 
following treatment with the pro-inflammatory cytokine cocktail and RCSC. Five genes 
were upregulated two-fold and ten genes were downregulated ≥two-fold. Cluster of 
differentiation 38 (CD38) was downregulated four-fold, while the cytokine interleukin 2 
(IL2) was downregulated 63-fold. Additionally, two genes, nuclear factor kappa-light-
chain- enhancer of activated B cells (NF-κB) and the oncogene (SKI) were independently 
upregulated in RCSC versus inflammation and plant medium controls (Table 1.2). 
Furthermore, four genes, C-C motif ligand 5 (RANTES/CCL5), human leukocyte antigen 
1 (HLA1), and inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
(IKBKB) were downregulated 2-fold and CD38 was downregulated 4-fold in RCSC 
versus inflammation and plant medium controls (Table 1.1). 
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Figure 1.25: Heap map evaluating expression of selected immune responsive genes. 
A. NCM 356 treated for 24 hours with the pro-inflammatory cytokine cocktail, followed 
by 48 hour treatment with RCSC or PM at a 1:40 dilution. B. CCD 841 CoN treated for 
24 hours with the pro-inflammatory cytokine cocktail, again followed by 48-hour 
A. B. 
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treatment with RCSC or PM at a 1:40 dilution. ΔCt was compared with untreated controls 
in both groups. Intensity of red or green color indicates up regulation and down-
regulation respectively. Map generated utilizing Pearson correlation.  
 
  
CCD 841 CoN gene expression profile was also investigated in order to identify 
possible molecular mechanisms. In RCSC versus inflammatory control groups, four 
genes, interleukin 1 alpha (IL-1A), granulysin (GNLY), colony-stimulating factor 2 
(CSF-2), and heme oxygenase decycling 1 (HMOX-1) were upregulated ≥4-fold (Table 
1.3). Conversely, 11 genes were downregulated two-fold in RCSC versus inflammatory 
control, with four genes being downregulated ≥4-fold which include B-cell lymphoma 2 
Table 1.1: Differentially regulated 
genes in RCSC vs. inflammatory 
control in NCM 356 
Table 1.2: Differentially regulated 
genes in RCSC vs. plant medium 
control in NCM 356 
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like 1/BCL2L1, SMAD family member 3/SMAD3, colony stimulating factor 1/CSF1, 
and C-X-C motif chemokine 10/CXCL10 (Table 1.3). 
 
 
Likewise, eight genes were upregulated in RCSC versus both inflammatory and 
plant medium controls, while six genes were downregulated. Of these, three genes, IL-
1A, GNLY, and CSF-2 were upregulated ≥4-fold (Table 1.4). On the other hand, three 
genes, SMAD3, CSF-1, and CXCL10 were ≥4-fold were downregulated. Three genes, 
CXCL10, SKI, and NF-κB were differentially regulated in both NCM 356 and CCD 841 
Table 1.3: Differentially regulated genes in RCSC 
vs. inflammatory control in CCD 841 CoN 
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CoN in RCSC treated versus inflammatory control group. All three genes were 
upregulated in NCM 356 while they were downregulated in CCD 841 CoN (Table 1.5).  
 
 
 
 
 
Table 1.4: Differentially regulated genes in RCSC 
vs. inflammation and PM controls 
Table 1.5: Differentially regulated genes in NCM356 and CCD 841 CoN 
when treated with RCSC versus both inflammation and PM controls 
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1.5 Discussion 
Maintenance of ROS generation and elimination is a critical mechanism in 
maintaining cellular homeostasis36. High oxidative stress has been shown to play a 
critical role in a multitude of diseases such as aging, cancer, and neurodegeneration36,37. 
ROS is produced from the reduction of molecular oxygen and includes radical species 
such as the hydroxyl radical and superoxide. ROS regulate cell survival in a dose 
dependent manner with moderate levels promoting cell proliferation and survival while 
high levels disrupting the required homeostasis36. Additionally, levels of ROS regulate a 
multitude of proteins required for cell adhesion, such as cell adhesion molecules 
(CAMS), which include selectins, integrins and some members of immunoglobulin 
superfamily37.  
 There are two main mechanisms of cell death, notably apoptosis and necrosis. 
Apoptosis has been characterized as programed cell death dependent on the execution of 
a family of cysteine dependent aspartate directed proteases, also known as caspases38. On 
the other hand, necrosis has been described as a spontaneous, accidental, uncontrollable 
process highly dependent on the homeostasis of calcium39.  Both apoptosis and necrosis 
are present in a wide range of pathologies from ischemia/reperfusion injuries, to 
neurodegeneration and inflammation38,39. In order to analyze the effects of the pro-
inflammatory cytokine cocktail on apoptotic cell death, propidium iodide was analyzed 
via fluorescent microscopy and flow cytometer. 
 InEpC treated with RCSC showed significant decrease in cytoplasmic ROS, while 
no change was observed in regards to nuclear ROS levels. The greatest reduction in ROS 
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was observed in InEpC, when compared to both CCD 841 CoN and NCM 356. Although 
inflamed NCM 356 cells treated with RCSC showed higher nuclear ROS at 1:40 dilution, 
following 48 hours incubation, their overall survival increased. Since NCM 356 
inappropriately expresses gastrin, and secretes functional gastrin peptides, this could be 
indicative of a pre-malignant state40. Because of the possible pre-malignant state of NCM 
356, this could also explain the increase in nuclear ROS. Higher levels of ROS have been 
correlated with increase in nuclear damage, because of the high reactivity of the free 
radical. ROS also acts as a transcriptional regulator mainly through interactions with NF-
κB. Treatment with RCSC revealed two fold increase in NF-κB expression versus all 
controls, possibly indicative of regulated signaling36. Also in both inflammatory and plant 
medium controls, IKBKB is upregulated two fold, versus RCSC again indicative of 
regulated signaling outside of canonical signaling which requires IKBKB degradation36.  
Since RCSC increased nuclear and cytoplasmic ROS and overall survivability 
increased, this implicates ROS acting in a positive manner. Acting in a positive fashion, 
ROS could be inhibiting the action of the pro-inflammatory cytokine cocktail. An 
important point to consider is the concentration of the cytokines (both TNF-α and IL-1β 
used at 100ng/ml) in the inflammatory cocktail, which is sufficient to directly initiate 
apoptosis. In RCSC treated samples, the overall number of living cells stained with 
NucBlue® fluorescent probe was much higher, versus both inflammation and plant 
medium. Since most cells appeared apoptotic or necrotic in inflammation and plant 
medium, cells treated with RCSC revealed drastic increase in nuclear generated ROS 
with minor increase in cytoplasmic ROS. Thus, increase in both nuclear and cytoplasmic 
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generated ROS by RCSC, could be the mechanism, which prevents cytokine induced cell 
death. TNF-α induced inflammation has been shown to induce ROS production through 
NADPH dependent oxidases41. This along with sustained JNK activation, a direct target 
of TNF-α, induces necrosis across multiple cell lines41. When NCM 356 was treated with 
the inflammatory cocktail and RCSC, NF-κB and BCL2L1 expression increased 2-fold in 
treated groups, which could account for the increase in survivability since NF-κB 
activation prevents both apoptosis and sustained JNK activation at normal levels, while 
BCL2L1 prevents TNF-α activation.  
The inflammatory and plant medium control groups both showed increase in 
nuclear ROS, which could be attributed to treatment with TNF-α as well. Increase in 
ROS production can hinder the function of MAPK phosphatase (MKP) by altering a 
critical cysteine residue through oxidation42. This impinges MKP function while 
rendering JNK constitutively active, thus causing cell death as seen in both inflammatory 
and plant medium controls42. IL-2 was upregulated in inflammatory and plant medium 
control 63-fold and RCSC was able to restore the expression to control levels. Sohn and 
colleagues have shown that absence of this cytokine can induce colon cancer in a chronic 
ulcerative colitis setting33. IL-2, along with other interleukin class molecules, have also 
been implicated in regulating the intestinal epithelium through TGF-beta dependent 
pathways. Therefore, normal regulation of this cytokine is critical in maintaining a 
healthy population43. It has been shown that abnormal increase in cytokines can lead to 
improper immune responses resulting in inflammation44. Mediation of this cytokine as 
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well as other by RCSC may be responsible for anti-inflammatory and anti-tumorigenic 
responses.  
CCD 841 CoN showed large increase in nuclear generated reactive oxygen 
species with mild increase in cytoplasmic generated ROS compared to all controls. This 
response can possibly be attributed to RCSC having some effect on mitochondrial 
NADPH oxidases. A major portion of ROS is generated in the mitochondria and is 
utilized for both cellular defense mechanisms, such as initiating the innate and adaptive 
immune response as well as cell signaling45. In terms of anti-inflammatory effects, the 
pro-inflammatory cytokine, interferon, stimulated interferon gamma induced protein 10 
(CXCL10) 8-fold in both inflammatory and PM controls of CCD 841 CoN, whereas 
RCSC was able to reduce the expression back to control levels.  This is a direct response 
related to the interactions of the pro-inflammatory cytokine cocktail46. Furthermore, this 
chemokine activates the signal transduction pathway involving the constitutively 
expressed Janus family kinases, Jak, Tyk2, and Stat1, 2, 3 and 547. Activation of this 
pathway has shown to be highly upregulated in inflammatory bowel disease. Treatment 
with RCSC was shown to further reduce the expression of STAT3, a strong oncogenic 
transcription factor by two-fold, indicating its immune-modulatory and anti-inflammatory 
effects. 
 The pro-inflammatory cytokine TNF-α has been extensively studied in IBD, and 
has shown to be greatly upregulated, with concentration dependent on disease 
progression48,49. Almost all known members of the TNF family form trimers that interact 
in a multitude of ways, from initiating a strong inflammatory response, to initiating cell 
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death. Most notably, strong interactions of TNF family with FAS work to induce cell 
death, as well as to initiate strong immune modulatory effects50. In both inflammatory 
and PM groups, FAS was upregulated two-fold, whereas RCSC was able to mitigate this 
response. This could be one of the main mechanisms in preventing cytokine induced cell 
death. Interestingly, IL-6 was upregulated in RCSC treated groups in CCD 841 CoN. It 
binds to form an active IL-6sIL-6R complex, which in turn activates STAT351. This 
response results in colitis, as well as triggering oncogenic event. However, IL-6 alone can 
prevent apoptosis, which could partially account for increased survivability in RCSC 
treated groups51. 
 
1.6 Conclusion and future work 
RCSC exhibits strong anti-inflammatory effects following high doses of pro-
inflammatory cytokines. Large increase in ROS suggested protective and immune 
modulating effect of RCSC. The extent to which RCSC impacts cellular function is 
dependent on downstream targets such as FAS, NF-κB, STAT3, CXCL10, IL-2, IL-6, as 
well as others, needed to maintain cellular homeostasis. Interleukin 2 expression 
increased several-fold following pro inflammatory cytokine treatment, and was reduced 
to control levels following RCSC possibly indicative of its mechanism of action. 
Additionally, CXCL10 and CSF-1 were downregulated several-fold compared to both 
inflammation and PM controls, further indicating its mode of action. Further research is 
needed to fully understand the effects in vivo and in vitro, specifically further elucidation 
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of molecular mechanisms, as well as uncovering the underlying metabolite(s) responsible 
for these effects. 
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Chapter 2: Isolation of Bioactive Fractions from Rice 
Callus Suspension Culture (RCSC) 
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2.1 Abstract 
Previous reports on RCSC have indicated strong anti-inflammatory and 
anticancer activity. We sought to identify the bioactive compounds and/or fractions 
responsible for such activity.  Twenty-five 1 ml fractions were isolated via column 
chromatography and further analyzed by high performance liquid chromatography 
(HPLC). A total of 6 peaks were identified in fractions 1-7, whereas fractions 8-25 
had 3 peaks. Fractions 10-18 were pooled and re-analyzed by HPLC utilizing an 
aqueous mobile phase: a total of 8 peaks were identified. Cell viability was assayed 
with whole RCSC and fractions 10-18 for anticancer activity using the colon 
adenocarcinoma cell line SW620. Furthermore, reactive oxygen species (ROS) 
assays were utilized to test for anti-inflammatory activity following treatment with a 
pro-inflammatory cytokine cocktail. RCSC and fractions 10-18 both significantly 
reduced the number of viable cells in SW620, while mild decrease was seen in CCD 
841 CoN. Additionally, RCSC fractions greatly increased nuclear and cytoplasmic 
ROS as analyzed by flow cytometry versus both untreated and inflammatory 
control. In conclusion, RCSC fractions 10-18 consists of compounds that are 
responsible for the anticancer, anti-inflammatory and immune regulating properties 
as previously reported. 
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2.2 Introduction 
Natural products are the most important source of medicinal drugs today52. World 
Health Organization (WHO) back in 1985 estimated that about 65% of the world 
population relied on plant derived medicinals3. Today, a plethora of these compounds are 
used to treat a wide variety of ailments. Eucalyptol for example, along with camphor, 
which are found readily in rosemary oil, have shown to contain anti-inflammatory and 
anti-cancerous activity52. The diterpenes, nigilactones, have shown anti-leukemic 
activity52. The anti-mitotic paclitaxel is used extensively to treat breast cancer52. Several 
flavones isolated from a variety of plant species have shown efficacy across the board. 
The compound acacetin, isolated from black locust, exhibits anti-inflammatory activity52. 
Furthermore, several flavanone derivatives show biological activity. The silymarins, 
present in milk thistle, are effective agents against liver damage as well as useful in 
prevention of skin cancer52. 
 The bioactive compounds of natural products are produced as “secondary 
metabolites” through four major pathways, malonic acid pathway, mevalonic acid 
pathway, non-mevalonate pathway, and shikimic acid pathway25,27,53. These pathways 
produce three main classes of compounds with several existing derivations, alkaloids, 
phenylpropanoids and allied phenolic compounds, and terpenoids1,22,24,26,28.  
 The list of natural products with medicinal properties is seemingly endless; 
several reviews, books, dictionaries and databases have been specifically dedicated to the 
understanding of these compounds52. The most challenging aspects of natural products, 
for use in modern medicine, revolve around isolation and purification. There are several 
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factors, which affect the final outcome such as type of plant tissue, solvent used, 
temperature, pressure and time54. Additionally, the extraction method chosen greatly 
affects the final outcome; therefore there is great need for a standard and integrative 
approach53.  
 Several different techniques have been utilized for natural product extraction. 
There are two main approaches, conventional and non-conventional techniques. The 
current conventional techniques are soxhlet extraction, maceration and/or hydro 
distillation53. The non-conventional techniques are enzyme-assisted extraction, 
ultrasound assisted extraction, supercritical fluid extraction, pressurized liquid extraction, 
and pulsed electric field assisted extraction53.  
 Recently, our group has reported potent anti-cancer and anti-inflammatory 
activity in rice callus suspension culture (RCSC). Our current aim is to isolate, purify, 
and characterize the bioactive compound in RCSC utilizing conventional extraction and 
purification techniques. This includes utilizing solvent-based extractions along with 
following methods for purification and structural determination: thin layer 
chromatography (TLC), column chromatography, high performance liquid 
chromatography (HPLC), and nuclear magnetic resonance spectroscopy (NMR.  
 Inflammatory bowel disease (IBD) has emerged as a dominant inflammatory 
condition affecting millions across the globe, 1.2 million in the United States alone. 
Moreover, IBD drastically impacts morbidity and quality of life for those affected55. 
Colorectal cancer, on the other hand, is the third most commonly diagnosed cancer 
55 
worldwide with around 700000 deaths annually56. In this study, we utilized an in vitro 
IBD model, along with a colorectal adenocarcinoma cell line SW 620 to identify possible 
bioactive metabolites in RCSC consistent with previous reports12,13. We identified and 
characterized an active fraction in RCSC with strong reactive oxygen species (ROS) 
modulating affects. Furthermore, the fractions had potent anticancer activity in vitro with 
minimal affects on the normal colon cell line CCD 841 CoN. 
 
2.3 Materials and methods 
2.3.1 Rice callus suspension culture 
Rice callus suspension culture was produced from Oryza sativa cultivar 
Nipponbare seeds from the United States Department of Agriculture (USDA) National 
Plant Germplasm System (NPGS) following the protocol as described by Deshpande et 
al.13. Seeds were incubated on solid MS medium supplemented with Chu’s N6 vitamins 
(PhytoTechnology Lab) and 2,4-dichlorophenoacetic acid (2,4-D) for 3 weeks at 28°C. 
Next, one 10mm petri dish of callus was added to 250ml of liquid callus induction 
medium and grown for an additional 3 weeks at 28°C on a shaker. Following 3 weeks, 
the liquid medium was collected, particulate matter and cell debris was removed through 
centrifugation at 10,000rpm for 10min at 4°C and filter sterilized through .2 micron 
filters. The culture was further aseptically aliquoted into 50 ml sterile culture tubes and 
stored at -20°C until further use. UV absorbance at 250nm-300nm was measured via 
Nanodrop.  
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2.3.2 Preparation of RCSC for phytochemical analysis and thin layer 
chromatography (TLC) 
1ml of RCSC was centri-vaped to remove callus liquid induction medium/water 
and then re-suspended in 1ml of 100% methanol, acetone, and/or ether. Samples were 
then applied to Thin Layer Chromatography (TLC; silica gel plates) and developed in 
various organic solvent combinations. Following development, compounds were 
identified by exposure to I2 vapors. Rf values were calculated for each compound. 
2.3.3 Column chromatography 
RCSC was further analyzed and separated via silica column chromatography to 
test and isolate active fractions. 500ml of RCSC was concentrated via rotary evaporation 
to 15ml to create a 33x concentrated solution. The solution was again filtered through a 
.2-micron filter and aseptically aliquoted into 50ml sterile centrifuge tubes. UV-visible 
spectrum was analyzed via Nanodrop. A 50ml column was packed with 10 - 40μm silica 
gel and soaked with a 20/80-methanol/chloroform solvent system. 1ml of 33x 
concentrated RCSC was added to the column and fractions were collected in 1ml vials. 
Next, each 1ml fraction was spotted on TLC plates and analyzed as described above. 
2.3.4 High Performance Liquid Chromatography (HPLC) 
RCSC was fractionated using high performance liquid chromatography (HPLC). 
RCSC was concentrated 33x (660mg/ml) as described above. 1ml was further centri-
vaped and re-suspended in 100% methanol and/or sterile deionized water as previously 
described12. 100μl of the sample was injected into a C18 reverse phase (Kinetex™) 
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and/or PFP column (Kinetex™) and fractionated using a photo diode array detector 
(Agilent Technologies). Compounds were separated using a binary gradient of 50% 
methanol (solvent A) and 50% acetonitrile (solvent B) and/or 5% acetic acid (Solvent A) 
and 50% acetonitrile (solvent B)12. Total run time was 60 minutes. 
2.3.5 Human colon adenocarcinoma cell line SW620 culturing, passaging, 
and seeding 
The cell line selected for high throughput screening of column chromatography 
and HPLC fractions was SW620 obtained from ATCC (American Type for Culture 
Collection). SW620 was cultured in Roswell Park Memorial Institute medium (RPMI-
1640) supplemented with 10% Fetal Bovine Serum (FBS) and 1% penicillin, 
streptomycin and amphotericin B solution (ATCC). Cells were frozen in 95% complete 
growth medium supplemented with 5% DMSO and stored in liquid nitrogen vapor phase 
until needed.  
 Cells were removed from liquid nitrogen and quickly thawed in 37°C water bath 
for no more then 1 minute. Next, cells were immediately placed in 10ml of complete 
growth medium and centrifuged to remove residual DMSO. 10ml of complete growth 
medium was added to the pellet and gently mixed and then further transferred to 100 x 20 
mm sterile culture dish. Cells were incubated at 37°C, 5% CO2, 95% humidity. 
 Once cells reached 70-90% confluence, medium was removed and cells were 
treated for 5-10 minutes with 3-4ml of trypsin-EDTA solution (Hyclone) to detach the 
monolayer as per manufacturer recommendations. 7ml of complete growth medium was 
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added to the culture dish to inactivate trypsin-EDTA solution. Then, cells were collected 
and centrifuged at 1000rpm. The pellet was then re-suspended in complete growth 
medium and either passaged or seeded at the appropriate density in 6, 12, 24, or 96 well 
plates. Cells were sub-cultured at 1:2 – 1:10 ratio as per manufacturer recommendations 
with media renewal 2 to 3 times per week.  
 Cell counting was done using a hemocytometer and trypan blue cell exclusion 
assay. Cells were first diluted to a 1:20 ratio with cell culture medium: 25μl of cells 
added to 475μl of cell culture medium. 50μl of the diluted sample was then added to 10μl 
of the trypan blue stain. Lastly, 10μl was added to the hemocytometer for cell counting. 
Cells were counted following the formula as described by Deshpande et al.13. Number of 
cells/mL = (X) * (20) * (1.2) * 104, where X = average number of cells in four squares, 
20 = first dilution factor, and 1.2 = second dilution factor. 
2.3.6 Normal human colon cell lines culturing, passaging, and seeding 
CCD 841 CoN (ATCC® CRL-1790™) was cultured in Eagle’s minimum 
essential medium (EMEM, ATCC® 30-2003) with 10% FBS at 37°C with 5% CO2. Cell 
dilution and counting was done as described above for SW620. Cells were grown until 
70-90% confluence, and then collected using trypsin EDTA. From there, cells were 
centrifuged and re-suspended in the appropriate cell culture medium for seeding. Seeding 
was done in 6, 12, 24, and/or 96 wells plates at appropriate density’s and incubated for 24 
hours at 37°C, 5% CO2 until further use. 
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Cell freezing protocol for CCD 841 CoN was done per manufacturer 
recommendations. The cell monolayer was detached following a 5-15 min treatment of 
trypsin-EDTA. From there 6-8ml of complete culture medium was added to inactivate the 
trypsin-EDTA solution. The cells were then collected and transferred into 50ml conical 
centrifuge tubes and centrifuged at 125 g for 5-10 minutes. The resulting cell pellet was 
furthermore re-suspended in complete growth medium and 5% DMSO. A stepwise 
temperature reduction was utilized for cell freezing. First, the cells were placed in 20°C 
for 24 hours, then -80°C for an additional 24 hours, and finally liquid nitrogen for long-
term storage. 
2.3.7 Treatment with pro-inflammatory cytokine cocktail 
In order to stimulate an inflammatory response in vitro, cells were treated with a 
pro-inflammatory cytokine cocktail consisting of TNF-α (100ng/ml, Sigma), IL-1β 
(100ng/ml, Sigma), LPS (10μg/ml, Sigma), and IFN-γ (5μg/ml, Sigma) suspended in 
PBS, for 0-24 hours prior to RCSC or PM treatment. 
2.3.8 in vitro cytotoxicity testing  
Previous literature has indicated strong anti-cancer activity of RCSC in multiple 
cell lines12,13. Therefore in order to test for bioactivity, SW620 was initially assayed with 
propidium iodide ReadyProbes® reagent using fluorescent microscopy and flow 
cytometry following treatment with each fraction. The fractions with like Rf values were 
pooled and rotary evaporated to remove methanol, then re-suspended in PBS and tested 
for bioactivity. SW620 was trypsinized and collected. Cells were then seeded in 12 well 
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plates and grown until 70-90% confluent. Cells were treated with a 1:5 dilution of each 
fraction for 24-48 hours and incubated at 37°C, 5% CO2, 95% humidity. Following the 
incubation period, the medium was removed, cells trypsinized and then collected and re-
suspended in HEPES based live cell imaging solution. Lastly, cells were treated with 
propidium iodide and analyzed via flow cytometry or fluorescent microscopy.  
Cytotoxicity and inflammatory responses were tested in normal colon cells (CCD 
841 CoN). Cells were cultured and seeded as per manufacturer recommendation. The 
cells were then treated for 48 hours with a 1:5 dilution of fractionated RCSC (HPLC 
fractions 10-18) and analyzed via flow cytometer with propidium iodide ReadyProbes®. 
Furthermore, reactive oxygen species (ROS) assays were utilized to analyze free radical 
scavenging and anti-inflammatory effects following treatment with a pro-inflammatory 
cytokine cocktail. Cells were treated with the pro-inflammatory cytokine cocktail for 24 
hours prior to 48-hour treatment with a 1:20 dilution of RCSC fraction. Following 
treatments, cells were analyzed for free radical scavenging capabilities utilizing 
CellROX® orange cytoplasmic and green nuclear ROS probes via flow cytometer under 
fluorescent laser 3 and 1 (FL3 and FL1), respectively. Statistical analysis of data was 
performed with one way ANOVA with Tukey’s test (p<0.05). 
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2.4 Results 
2.4.1 TLC plates identified spots in RCSC with different Rf values 
Thin layer chromatography was performed with RCSC, and 3x and 33x 
concentrated RCSC solution (Figure 2.1) in order to determine approximately the number 
of compounds in RCSC. Different running solvents and ratios were utilized. Distilled 
water was the initial extraction solvent and methanol was used thereafter. The Rf values 
for compounds identified are listed below in Table 2.1. 
 
A. 
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B. C. 
D. E. 
RCSC 
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Figure 2.1: Images of RCSC. A. From left to right imaged RCSC, 3x, and 33x 
concentrated RCSC. B. Methanol extract of concentrated RCSC, which produced an oily 
sap like substance. C. Methanol extract showing UV activity. D. Methanol extract in 
DDH20, poor solubitlity. E. Column chromatography of 33x Concentrated RCSC running 
through silica gel.  
  Table 2.1 Rf values for compounds identified in RCSC 
Sample Extraction Solvent Running Solvent Rf Value 
Compound 1 = .83  
Compound 2 = .61 
Compound 3 = .19 
Compound 1 = .9 
Compound 2 = .7 
Compound 1 = .93 
Compound 2 = .58 
Compound 1 = .54 
Compound 2 = .33 
RCSC 
3x  
Aqueous 20/80 
Methanol/Chloroform  
.93 
RCSC 
33x 
 
Aqueous 20/80 
Methanol/Chloroform 
.41 
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2.4.2 Fractionation of RCSC with column chromatography and HPLC 
Column chromatography was utilized to separate compounds from the 33X 
concentrated RCSC solution.  A total of twenty-five 1ml fractions (Figure 2.2) were 
collected with varying mobile phases. Fractions 1-7 were collected utilizing a 20/80 
methanol/chloroform mobile phase. Fractions 8-25 were collected via a 100% methanol 
mobile phase.  Each fraction was further analyzed by HPLC on a C18 column with 50/50 
methanol/acetonitrile mobile phase, with UV 255nm for compound identification (Figure 
1). Fractions 1-7 yielded 6 different peaks, while fractions 8-25 yielded 3 different peaks. 
Fractions 10-18 were pooled and further analyzed by HPLC on a C18 column with 100% 
HPLC grade water as the mobile phase. A total of 8 peaks were identified, peak 6 was 
UV excited (Figure 2.3) whose bioactivity has to be tested. 
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Figure 2.2: HPLC chromatogram of the 25 fractions collected via column 
chromatography. Each fraction was analyzed on a C18 column with a 50/50 
methanol/acetonitrile mobile phase, flow rate 1ml/min, UV 255nm. 
   
Figure 2.3: HPLC chromatogram of fractions 10-18. Fractions analyzed on a C18 
column with a 100% HPLC grade water mobile phase, .5ml/min flow rate, 10 min total 
run time, UV 255nm. 
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2.4.3 RCSC and concentrates induced rapid cell death in human colon 
adenocarcinoma cell line SW620 
RCSC was tested for anticancer activity using propidium iodide staining with 
fluorescent microscopy and flow cytometry against the human colon adenocarcinoma cell 
line, SW620. Furthermore, a dose response curve was constructed using 1x, 3x, 6x and 
33x concentrated RCSC. Treatment of SW620 with a 1:5 dilution of RCSC after 5 
minutes resulted in minor increase in fluorescence, while after 10 minutes significant 
increase in fluorescence was observed (Figure 2.4).  
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Figure 2.4: RCSC induces rapid cell death on the human colon adenocarcinoma cell 
line SW620 as analyzed by fluorescent microscopy. A. Real time imaging of SW620 
assayed with propidium iodide cell viability assay following treatment with a 1:5 dilution 
of RCSC. Pictures acquired at 5 min intervals. Images taken using a Leica inverted 
fluorescent microscope at 200x, excitation/emission 533nm/617nm. B. Quantification of 
real time imaging of RCSC treatment with propidium iodide cell viability assay. *= 
indicates significance vs. non treated control. Results analyzed utilizing one way 
ANOVA with Tukeys test (n=5, p<0.05). 
SW620 analyzed by flow cytometer following a 1:5 dilution for 30 minutes of 1x, 
3x, 6x, and 33x RCSC resulted in a dose dependent death response based on propidium 
iodide staining (Figure 2.5). RCSC increased cell death to 7.7%, 3x concentrated RCSC 
to 18.9%, 6x RCSC to 77.1%, and 33x to 78% versus untreated control at 5% (Figure 
4A).  Additionally, the dose response curve calculated using the above concentrations 
resulted in an EC50 dilution factor being 3.64 (Figure 2.5). The EC50 value represents the 
dilution factor of the compound in which 50% of the maximal effect is observed, in this 
case 50% of the SW620 cells would die following treatment with RCSC at a 1:3.64 
dilution of the 3x/6x concentrated RCSC. Data was analyzed utilizing one-way ANOVA 
with Tukey’s test (p<0.05) for both fluorescent microscopy and flow cytometry (n=5).  
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Figure 2.5: RCSC, concentrates, and fractions 10-18 rapidly induce cell death 
following 30-minute treatments of a 1:5 dilution. A. The colon adenocarcinoma cell 
line SW620 treated for 30 minutes with RCSC, concentrates, and fractions 10-18 at a 1:5 
dilution utilizing propidium iodide cell viability assay. B. Graphical representation of the 
lowest effective dose, EC50 value, calculated using the varying concentrates. C. Bar graph 
showing dose response of RCSC concentrates on SW620 cell line. *= indicates 
significance vs. non treated control. Results analyzed utilizing one way ANOVA with 
Tukeys test (FL3 laser 670nm, p<0.05). 
2.4.4 RCSC and fractions 10-18 significantly increased cell death in human 
colon adenocarcinoma cell line SW620 comparable to whole RCSC 
Fractions 10-18 were analyzed by fluorescent microscopy and flow cytometry 
with propidium iodide staining for anti-cancer activity against the adenocarcinoma cell 
line, SW620. Similar HPLC peaks resulted in pooling of the selected fractions for testing, 
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as they likely contained the same compounds. A 1:5 dilution was utilized for testing of 
the fractions, as this dilution factor resulted in the greatest inhibitory effect by RCSC on 
SW620. Following a 30-minute treatment with fractions 10-18, significant increases in 
fluorescence versus untreated control was observed when viewed under Leica fluorescent 
microscope indicating a reduction in the number of viable cells (Figure 2.6). 
Additionally, cells showed characteristics of apoptosis such as nuclear condensation and 
visual apoptotic bodies (Figure 2.6).  
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Figure 2.6: RCSC fractions 10-18 induced rapid cell death in the human colon 
adenocarcinoma cell line SW620 as analyzed by fluorescent microscopy. A. Real 
time imaging of SW620 assayed with propidium iodide cell viability assay following 
treatment with a 1:5 dilution of RCSC fractions 10-18. Pictures acquired at 30 min 
intervals. Images taken using a Leica inverted fluorescent microscope at 200x, 
excitation/emission 533nm/617nm. B. Quantification of real time imaging of RCSC 
fractions 10-18 treatment with propidium iodide cell viability assay. *= indicates 
significance vs. non treated control. Results analyzed utilizing one way ANOVA with 
Tukeys test (n=5, p<0.05). 
Furthermore, when flow cytometry was used to analyze propidium iodide stained 
cells, fractions 10-18 revealed significant increase in cell death versus untreated control, 
recording 65.1% and 5% dead cells, respectively (Figure 2.5). Data was analyzed 
utilizing one-way ANOVA with Tukey’s test (n=5, p<0.05) for both fluorescent 
microscopy and flow cytometry. 
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2.4.5 RCSC and concentrates mildly increased cell death in normal human 
colon cell line CCD 841 CoN 
RCSC and concentrates were tested for effects on cell death using the normal 
colon cell line CCD 841 CoN with propidium iodide staining and flow cytometry. CCD 
841 CoN was treated for 48 hours with 1x, 3x, 6x, and 33x concentrated RCSC for 48 
hours. Cell death increased slightly in the 1x RCSC group to 9.6%, 11.8% in the 3x 
treated, 6x to 21.4%, and 33x to 22.1% versus 4.4% in the untreated control (Figure 2.7).  
Furthermore, a dose response curve was generated using the above concentrates and 
resulted in EC50 dilution factor of 4.38 (Figure 2.7). Data was analyzed utilizing one-way 
ANOVA with Tukey’s test (p<0.05).  
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Figure 2.7: RCSC, concentrates, and fractions 10-18 had minimal toxicity in the 
normal colon cell line CCD 841 CoN. A. The normal colon cell line CCD 841 CoN was 
treated for 30 minutes with RCSC, concentrates, and fractions 10-18 at a 1:5 dilution 
utilizing propidium iodide cell viability assay. B. Graphical representation of the lowest 
effective dose, EC50 value, calculated using the varying concentrates. C. Bar graph 
showing dose response of RCSC, concentrates, and fractions 10-18 on CCD 841 CoN 
cell line. *= indicates significance vs. non treated control. Results analyzed utilizing one 
way ANOVA with Tukeys test (FL3 laser 670nm, p<0.05). 
2.4.5 RCSC fractions 10-18 resulted in mild increases in cell death, but 
showed less toxicity than whole RCSC on the normal human colon 
cell line CCD 841 CoN 
Fractions 10-18 were tested for cell death on normal human colon cell line CCD 
841 CoN using propidium iodide and flow cytometry. Mild increase in fractions 10-18 
versus untreated control fluorescence (8.5% versus 4.4%) due to propidium iodide was 
observed (Figure 2.7). Additionally, fractions 10-18 were collected using 33x 
concentrated RCSC that showed 22.1% fluorescence corresponding to dead cells. These 
results indicate that the purification of fractions 10-18 reduced the toxicity in 33x 
concentrated RCSC. Data was analyzed utilizing one-way ANOVA with Tukey’s test 
(p<0.05) for flow cytometry (n=5).  
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2.4.6 RCSC fractions 10-18 increased nuclear and cytoplasmic ROS in the 
normal human colon cell line CCD 841 CoN 
RCSC fractions 10-18 were tested for ROS scavenging capabilities following 24-
hour treatment with the pro-inflammatory cytokines, TNF-α, IL-1β, IFN-γ, and LPS. 
Following a 48-hour treatment period, nuclear ROS increased to 8.8% compared to 4.8% 
in untreated control, and 5.8% in inflammation treated control, as analyzed by flow 
cytometry under FL1 (Figure 2.8).  
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Figure 2.8: RCSC fractions 10-18 increased nuclear ROS in CCD 841 CoN similarly 
to whole RCSC as analyzed by flow cytometer. A. CCD 841 CoN cells were treated 
with the pro inflammatory cytokine cocktail for 24 hours and RCSC fractions 10-18 for 
an additional 48 hours before analysis using CellROX® Green nuclear stain under 
fluorescent laser one (530 nm). *= indicates significance vs. non treated control, &= 
indicates significance vs. inflammatory control. Results analyzed utilizing one-way 
ANOVA with Tukeys test, p<0.05. Analysis was done on BD Accuri™ C6 flow 
cytometer. 
Cytoplasmic ROS also increased following treatment with fractions 10-18 to 
7.4% versus 3.7% in untreated control group, 4.8% in inflammation treated group, as 
analyzed by flow cytometer under FL3 (Figure 2.9). Data was analyzed utilizing one-way 
ANOVA with Tukey’s test (p<0.05) for flow cytometry (n=5). 
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Figure 2.9: RCSC fractions 10-18 increased cytoplasmic ROS in CCD 841 CoN 
similarly to whole RCSC as analyzed by flow cytometer. A. CCD 841 CoN cells were 
treated with the pro inflammatory cytokine cocktail for 24 hours and RCSC fractions 10-
18 for an additional 48 hours before analysis using CellROX® orange cytoplasmic stain 
under fluorescent laser three (670 nm). *= indicates significance vs. non treated control, 
&= indicates significance vs. inflammatory control. Results analyzed utilizing one-way 
ANOVA with Tukeys test, p<0.05. Analysis was done on BD Accuri™ C6 flow 
cytometer. 
 
2.5 Discussion  
Our current aim was to identify the possible bioactive compounds in RCSC 
responsible for the anti-cancer, and anti-inflammatory effects as described in previous 
literature published and unpublished12,13. Although we were unable to identify a specific 
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compound responsible for such activity, we were able to identify 8 peaks which most 
likely correspond to specific compounds, as described above, with activity similar to 
previous reports.  
 Several different extraction solvents were used and then spotted for possible 
compound identification, methanol and/or methanol/chloroform however seemed to be 
superior in separating the compounds isolated from the aqueous solution. When running 
the samples with HPLC on a C18 column, an aqueous mobile phase seemed to increase 
separation on the column compared to using methanol alone as the mobile phase.  
Additionally, we knew the compound shows absorbance in UV range, as the longer the 
incubation period for generating RCSC, the greater the absorbency. This gave us another 
clue as to how to identify the possible fraction based on UV absorption spectrum. 
Furthermore, absorbance in UV spectrum provides information about the chemical 
structure of the compound or compounds. RCSC fractions 10-18 showed absorbance in 
UV range and when further analyzed by HPLC, peak 6 maintained the absorbance when 
exposed to UV light. In most cases, this is indicative of conjugation or functional groups 
within the compounds. Furthermore, when methanol was rotary-evaporated, a sap like 
substance was produced which exhibited poor solubility in water and PBS, suggestive of 
a more hydrophobic compound. 
 In order to understand if RCSC fractions 10-18 were responsible for anti-cancer 
and anti-inflammatory activity, we utilized the colon adenocarcinoma cell line, SW620 
and the normal colon cell line, CCD 841 CoN with various assays as described above. 
Fractions 10-18 were collected using the 33X concentrated RCSC sample, therefore both 
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should contain roughly the same concentrations for testing purposes. When it came to 
testing RCSC and/or the fractions on SW620, both reported high anti-cancerous activity 
(>65% death). Furthermore, when RCSC and fractions 10-18 were tested on the normal 
colon cell line CCD 841 CoN, fractions 10-18 were less toxic on the normal cell line 
versus all other RCSC samples (1X, 3X, 6X, and 33X). This is possibly due to the 
concentration of the active compound(s) (unknown), or from the removal of any toxic 
compounds in the aqueous RCSC solution. In either case, RCSC fractions 10-18 
continued to exhibit selectivity towards cancerous cell lines, with minimal toxicity 
towards normal cells.  
 Previous unpublished literature suggests RCSC to have anti-inflammatory and 
immune-modulating properties. To identify if these properties were maintained in RCSC 
fractions 10-18, CellROX™ green and orange dyes were tested for free radical 
scavenging capabilities. RCSC alone increased both nuclear and cytoplasmic generated 
ROS, while increasing cell survivability following treatment with a pro-inflammatory 
cytokine cocktail. We concluded fractions 10-18 to exhibit similar results, however the 
response was reduced.  
ROS has been shown to participate in a multitude of signaling pathways 
responsible for both the induction and removal of the inflammatory response57. To this 
day, there is no clear-cut answer as to whether or not it plays a beneficial or detrimental 
role in biological systems. We do however know cancer cells generate and utilize high 
amounts of free radicals to initiate proliferation as well as increase antioxidant defense 
mechanisms57. This crucial need to maintain homeostasis can result in the explosion or 
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elimination of tumorigenic cells. In regards to cancer therapy, a review on treatments 
with antioxidants β-carotene, vitamin A, and vitamin C resulted in no significant benefit 
and in some cases resulted in deleterious effects57,58. Moreover, there is accumulating 
evidence for the use of small molecules, which are able to selectively target and disable 
the antioxidant pathways utilized in cancer cells59-61. 
  In inflammatory systems, ROS homeostasis is crucial for generating the 
appropriate immune response. ROS seems to be intimately linked with both T- and B- 
cell function. Administration of antioxidants seems to diminish both T- and B- cell 
receptor signaling, which is crucial for mounting the proper immune response. As in 
tumorigenic tissue, generation and elimination of ROS determines if the response is 
beneficial or detrimental. For example, in mice lacking uncoupling protein 2 (UCP2), 
elevated ROS levels increased their immunity to bacterial infections, thus indicating a 
beneficial role of moderate increases in ROS levels. Additionally, mice heterozygous for 
mitochondrial hydroxylase necessary for ubiquinone synthesis (Mclk1) have elevated 
mitochondrial ROS levels along with elevated innate and adaptive immune responses that 
aid in pathogen defenses without harming surrounding tissue62. On the contrary, 
antioxidants have shown to be beneficial in NRF2-deficient mice, because of their 
inability to regulate ROS generation and elimination63,64. Lastly, ROS is an inevitable 
byproduct of aerobic metabolism, while several decades of research have been focused 
on the notion of ROS being responsible for several deleterious biological effects; this 
seems not to be the case65-67. Instead, recent evidence is strongly suggestive of ROS being 
required for proper maintenance of immune function and positively promotes healthy 
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tissue generation and repair68,69. In conclusion, the responses observed in our study of 
increased ROS levels as a result of treatment with RCSC fractions 10-18 containing the 
bioactive compound or compounds responsible suggest anti-cancerous and anti-
inflammatory activity.  
2.6 Conclusion and future directions 
RCSC fractions 10-18 exhibit similar responses as whole RCSC on both colon 
adenocarcinoma cell line SW620 and the normal colon cell line CCD 841 CoN indicating 
the possibility of one or more of the compounds corresponding to eight peaks being 
responsible for the observed effects. The next step would be to isolate the individual 
compounds and test for efficacy. From there, structural determinations would need to be 
performed to gain a greater understanding of possible biochemical and molecular targets. 
Finally, isolation of a single compound could provide a new anticancer and anti-
inflammatory compound with future clinical applications. 
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Chapter 3: Anti-inflammatory Effects of Northern 
Highbush Blueberry Extract on Two Inflamed Colon 
Epithelial Cell Lines 
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3.1 Abstract 
Blueberries have been described for decades as a “super food”. Several 
epidemiological studies have indicated blueberry polyphenols to exhibit potent anti-
inflammatory, anti-tumorigenic, and anti-oxidant capabilities in-vivo and in-vitro. 
While found abundantly within the human diet, the bioavailability of these 
compounds remains localized to the gastrointestinal tract (GI). Several studies have 
indicated that blueberry anthocyanins have the ability to efficiently reach the GI 
tract and exhibit a broad range of biochemical effects. Furthermore, in the context 
of inflammatory bowel disease (IBD), blueberry anthocyanins remain a promising 
complement to current IBD treatments. Here, we investigated the anti-
inflammatory and antioxidant capabilities of Highbush blueberries in-vitro on two 
normal colon epithelial cell lines, NCM 356 and CCD 841 CoN, following 
stimulation with a pro-inflammatory cytokine cocktail. Antioxidant and anti-
inflammatory properties were examined via fluorescent microscopy and flow 
cytometry utilizing various fluorescent probes. Treatment with phenolic rich 
blueberry extract revealed drastic decrease in nuclear and cytoplasmic generated 
reactive oxygen species (ROS) compared to controls. Additionally, the phenolic rich 
blueberry extract increased cell viability following treatment with the pro-
inflammatory cytokine cocktail. Here, in conjunction with current literature, we 
describe a phenolic rich blueberry extract to exhibit potent anti-inflammatory and 
anti-oxidant capabilities. 
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3.2 Introduction 
3.2.1 Inflammation and Inflammatory Bowel Disease (IBD) 
Inflammation has been described for as long as medicine itself has been around. 
In ancient times, it was simply described as red, hot, swollen skin70. It wasn’t until the 
late 1800s when Julius Friedrich Cohnheim first revealed the classical understanding of 
inflammation; vasculature changes, infiltration of white blood cells, and systemic 
changes71. Furthermore, fast forward 100 years later to 1977 and this still holds true, 
albeit a more specific and modified understanding70. Today, our understanding has vastly 
expanded. Inflammation, in general, is a response to any injury with a sole purpose to 
heal the affected tissue. This begins with a multitude of events, including activation and 
migration of neutrophils, monocytes, and eosinophils71,72. From there, a more specific 
response is initiated via the cross talk with cytokines and chemokines. These work as 
chemoattractant molecules to signal specific leukocyte populations, dependent on 
injury72. Additionally, this response can either be acute or chronic, dependent on the 
duration of the mediating factors. Wound healing for example is usually an acute 
response, while viral infections can lead to a more chronic response and possible 
neoplastic growth72. 
Inflammatory bowel disease (IBD) includes a multitude of inflammatory 
conditions affecting the gastrointestinal tract, notably of which Crohn’s disease (CD) and 
ulcerative colitis (UC) are the most common73. These conditions affect roughly 1.4 
million people in the US and Canada, with increasing incidents worldwide18,73. Ulcerative 
colitis is defined by specific pathological features, which include diffused inflamed 
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mucosa, severe inflammation, and production of a plethora of inflammatory chemical 
mediators. On the other hand, the pathology of CD is characterized by the presence of 
macrophage aggregates, which produce non-necrotizing granulomas18. In either case, the 
general attribute of IBD is disrupted inflamed intestinal epithelium74.  
The current treatment for IBD has been focused around maintenance of several 
pro-inflammatory cytokines, specifically TNFα and IFNγ20. Several studies in mouse 
models have implicated these cytokines, as well as the interleukin class of molecules in 
the pathogenesis of IBD20,75. These compounds are able to strongly regulate the immune 
response as well as drive intestinal and systemic inflammation20. For example, TNFα is 
able to regulate angiogenesis, Paneth cell death, macrophages, effector T cells, as well as 
the production of matrix metalloproteinases, all through binding to TNFR1 and TNFR2 
receptors20,76-79. These actions, in turn, result in disruption of the epithelial barrier as well 
as apoptosis77. Additionally, IFNγ has been shown to strongly increase vascular 
permeability and regulate cellular angiostasis in Dextran Sodium Sulfate (DSS) model of 
colitis in mice80.  
Furthermore, while a plethora of literature suggests these cytokines and others as 
good targets for treatments, the reality is not as straightforward. Currently, the anti-TNF 
therapy drug, infliximab, has had mixed results, but it continues to be the first line of 
defense in treatment of IBD20. On the other hand, the anti-IFNγ drug, fontolizumab, was 
unsuccessful in patients with CD20,81,82. This, along with the strong adverse side effects of 
similar anti-cytokine therapies, suggests a need for alternative and/or cooperative 
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therapies83. Dietary interventions are one of those alternatives, which have been shown to 
reduce and even eliminate inflammation through several different means.   
3.2.2 Anti-inflammatory effects of northern highbush blueberry extract 
polyphenols 
 For decades, blueberries have been touted for their beneficial health claims, from 
anti-inflammatory and anti-tumorigenic, to providing protection against oxidative stress 
and chronic conditions84. These effects are known to come from a complex class of 
compounds, termed secondary metabolites29. Secondary metabolites are divided primarily 
into three groups, which include terpenoids, alkaloids, and phenylpropanoids and other 
phenolic compounds1,5.  Blueberries are an abundant source of the phenolic class of 
bioactive compounds. Over 10 compounds have been identified, with as many as 15, with 
the content varying dependent on genetic and environmental factors85,86. For instance, 
highbush blueberries (Vaccinium corymbosum, L.) contain 15 different bioactive 
compounds, mainly delphinidin, cyanidin, petunidin, peonidin, and malvidin, with 
variation existing in number of hydroxyl groups, amount of methylation, as well as type 
and location of sugar molecules85,86. Wild blueberries (Vaccinium angustifolium), 
additionally, contain 15 different compounds, with differences being the identification of 
chlorogenic acid and an unknown compound84.  
Our current aim is to investigate the anti-inflammatory properties of highbush 
blueberries on two inflamed colon epithelial cell lines: NCM 356 and CCD 841 CoN. 
Furthermore, we aim to mimic in vivo conditions of IBD by in vitro treatment with pro-
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inflammatory cytokines: interlukin 1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), 
interferon gamma (IFN-ϒ), and lipopolysaccharide (LPS). 
 
3.3 Materials and methods 
3.3.1 Human colon cell lines 
Two human colon cell lines were used, NCM 356 and CCD 841 CoN. NCM 356 
was licensed and obtained from INCELL (San Antonio, TX) for three years. NCM 356 
was cultured and maintained in INCELL’s M300A, 10% fetal bovine serum (FBS) at 
37°C, 5% CO2 as per manufacturer recommendations. CCD 841 CoN (ATCC® CRL-
1790™) was purchased from ATCC (Manassas, VA) and cultured in Eagle’s minimum 
essential medium (EMEM, ATCC® 30-2003) with 10% FBS at 37°C, 5% CO2 as per 
manufacturer recommendations. Penicillin-streptomycin-amphotericin B solution was 
purchased from ATCC (ATCC® PCS-999-002). 
3.3.2 Cell counting, freezing, and seeding protocol 
Cells were counted using a hemocytometer following the general trypan blue cell 
exclusion assay. CCD 841 CoN was grown until 70-90% confluent and collected using 
trypsin EDTA. Cells were centrifuged and then re-suspended in the appropriate culture 
medium. Cells were counted utilizing the following formula:  Number of cells/mL = (X) 
* (20) * (1.2) * 104, where X = average number of cells in four squares, 20 = first dilution 
factor, and 1.2  = second dilution factor. Seeding was done in 6, 12, 24, or 96 well plates 
at the needed cell density and further incubated for 24 hours at 37°C, 5% CO2. 
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 CCD 841 CoN was frozen and stored in liquid nitrogen following the protocol 
below: cells were collected using 3-4ml of trypsin EDTA for 5-15 minutes followed by 
treatment with 6-8ml of complete cell culture medium to inactivate the trypsin. Cells 
were then placed in 50ml conical centrifuge tubes and centrifuged at 125 x g for 5-10 
minutes as per manufacturer recommendation. The cell pellet was re-suspended in 
complete growth medium with 5% DMSO. A stepwise temperature reduction was 
utilized for freezing: -20°C for 24 hours, -80°C for an additional 24 hours, and then liquid 
nitrogen for long-term storage.  
 NCM 356 was cultured and frozen as per manufacturer recommendation. The 
floating cells and medium were collected and transferred to 50ml tubes and centrifuged at 
500 x g for 5-10 min. The cell monolayer was washed with calcium and magnesium free 
phosphate buffered saline. 
3.3.3 Phenolic rich blueberry extract 
Northern highbush blueberries were collected from Gierke Blueberry Farm 
(37915 Klingville Road, Chassell, MI 49916) and immediately frozen in liquid nitrogen. 
For long-term storage, blueberries were placed in -80°C freezer. From there, 20 grams of 
frozen blueberries were ground in liquid nitrogen and placed into 50 ml VWR® 
SuperClear™ ultra-high performance centrifuge tubes. 10g of ground blueberry was 
dissolved in 20ml of a 70/29/1 ethanol, DI water, and 3% trifluoroacetic acid (TFA) 
solution. The solution was further filtered through Corning® 500ml 0.22μm 
polyethersulfone (PES) membrane and stored in -80°C freezer. 1ml of blueberry extract 
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was centrifuged under vacuum to remove solution and then re-suspended in 1ml of 
phosphate buffered saline (PBS) and stored in -80°C freezer until use on cells. 
3.3.4 Treatment of normal human colon cell lines with pro-inflammatory 
cytokine cocktail and blueberry extract 
Two normal colon epithelial cell lines were utilized to determine the anti-
inflammatory and anti-oxidant capabilities of a phenolic rich blueberry extract. In order 
to simulate conditions of IBD in vitro, cells were treated with a pro-inflammatory 
cytokine cocktail consisting of TNF-α (100ng/ml, Sigma), IL-1β (100ng/ml, Sigma), LPS 
(10μg/ml, Sigma), and IFN-γ (5μg/ml, Sigma) suspended in PBS for 24 hours prior to 
treatment with blueberry extract.  
3.3.5 Fluorescent microscopy 
NCM 356 and CCD 841 CoN were cultured as per manufacturers 
recommendations. Cells were seeded in triplicates in 6, 12, 24, or 96 well plates in 
appropriate medium with 3% heat-inactivated FBS at 25,000-100,000 cells per milliliter. 
Cells were imaged using either a Zeiss or Leica inverted fluorescence microscope 
following 24-hour treatment with a pro-inflammatory cytokine cocktail consisting of 
TNF-α, IL-1β, LPS, and IFN-γ prior to treatment for 24-96 hours with blueberry extract 
or PBS. Three fluorescent probes were used: Propidium iodide cell viability dye 
(ThermoFisher Scientific), CellROX® Green Reagent and CellROX® Orange Reagent 
for nuclear and cytoplasmic oxidative stress detection. Real time imaging was performed 
with propidium iodide on a Leica inverted fluorescence microscope at 1 min intervals for 
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10 min, and then 10 min intervals until 1 hour. Cell fluorescence was quantified utilizing 
Image J software. Calculated total cell fluorescence (CTCF) = Integrated Density – (Area 
of selected cell X Mean fluorescence of background readings). In order to compare 
fluorescence within and between groups, t-test, and 2-way ANOVA with Tukey’s post 
hoc test for pairwise comparison was utilized. All values are represented as mean±SEM 
and considered significant at p<0.05. 
3.3.6 Flow cytometry 
NCM 356 and CCD 841 CoN were seeded in 6, 12 or 24 well Nunc™ cell culture 
treated plates (ThermoFisher Scientific) until 70-90% confluent. Cells were then treated 
with a pro-inflammatory cytokine cocktail for 24 hours prior to 24-96 hour treatment 
with blueberry extract or PBS. Cells were assayed with propidium iodide for cell viability 
analysis under FL3, CellROX® Green Reagent and CellROX® Orange Reagent for 
nuclear and cytoplasmic oxidative stress detection under FL1 and FL3, respectively. Data 
was analyzed utilizing t-test, and 2-way ANOVA with Tukey’s post hoc test for pairwise 
comparison. Values are represented as mean±SEM with significance considered at p<0.05. 
 
3.4 Results 
In order to test the anti-inflammatory and antioxidant capabilities of a phenolic rich 
blueberry extract, we employed fluorescence microscopy and flow cytometry to 
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determine their free radical scavenging capabilities and effect on cell viability following 
the addition of inflammatory mediators.  
3.4.1 Blueberry extract significantly reduced nuclear and cytoplasmic ROS 
in inflamed human colon epithelial cells based on fluorescent 
microscopy 
NCM 356 cells subjected to 24-hour inflammatory cocktail treatment followed by 
treatment with 1:20 dilution of blueberry extract for 48 hours revealed drastic decrease in 
CellROX® green nuclear ROS reagent in blueberry treated groups versus inflammatory 
control (Figure 3.1 and 3.2). Similar treatment on CCD 841 CoN with blueberry extract 
showed significant decreases in CellROX® green nuclear ROS reagent fluorescence 
compared to inflammatory and vehicle control groups (Figure 3.7 and 3.8). NCM 
treatment with CellROX® orange cytoplasmic ROS reagent revealed significant decrease 
in cytoplasmic ROS following blueberry treatment versus both inflammatory and vehicle 
controls (Figure 3.3 and 3.4). Similar observation was made in CCD 841 CoN treated 
with blueberry extract, which showed significant decrease in cytoplasmic ROS versus 
vehicle control (Figure 3.9 and 3.10). Additionally nuclear staining with Hoechst 33342 
resulted in less nuclear condensation in blueberry treated groups versus all controls in 
NCM 356 (Figure 3.5 and 3.6) 
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Figure 3.1: Phenolic rich blueberry extract greatly reduced nuclear ROS in NCM 
356 cell line. NCM 356 cells were treated for 24 hours with the pro-inflammatory 
cytokine cocktail, followed by a 1:20 dilution of PBS or blueberry extract and assayed 
with CellROX® green nuclear ROS staining. (A) Control (B) Inflammatory control (C) 
1:20 PBS control and (D) 1:20 blueberry extract. Images were taken at 20x magnification 
using a Zeiss inverted fluorescent microscope. 
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Figure 3.2 Summary data of blueberry extract nuclear ROS in NCM 356 cell line. 
Quantification of CellROX® green nuclear ROS assay; all images were taken at 20x 
magnification using Zeiss inverted fluorescent microscope.  *= indicates significance vs. 
non treated control, &= indicates significance vs. inflammatory control, #= indicates 
significance vs PBS control. Results analyzed utilizing one-way ANOVA with Tukeys 
test, n=5 p<0.05. 
    
   
Figure 3.3: Phenolic rich blueberry extract greatly reduced cytoplasmic ROS in 
NCM 356 cell line. NCM 356 cells were treated for 24 hours with the pro-inflammatory 
cytokine cocktail, followed by a 1:20 dilution of PBS or blueberry extract and assayed 
with CellROX® orange cytoplasmic ROS staining. (A) Control (B) Inflammatory control 
(C) 1:20 PBS control and (D) 1:20 blueberry extract. Images were taken at 20x 
magnification using a Zeiss inverted fluorescent microscope. 
A. B. 
C. D. 
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Figure 3.4 Summary data of blueberry extract cytoplasmic ROS in NCM 356 cell 
line. Quantification of CellROX® orange cytoplasmic ROS assay; all images were taken 
at 20x magnification using Zeiss inverted fluorescent microscope. *= indicates 
significance vs. non treated control, &= indicates significance vs. inflammatory control, 
#= indicates significance vs PBS control. Results analyzed utilizing one-way ANOVA 
with Tukeys test, n=5 p<0.05. 
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Figure 3.5: Phenolic rich blueberry extract reduced nuclear condensation in NCM 
356 cell line. NCM 356 cells were treated for 24 hours with the pro-inflammatory 
cytokine cocktail, followed by a 1:20 dilution of PBS or blueberry extract and assayed 
with Hoechst 33342 nuclear stain. (A) Control (B) Inflammatory control (C) 1:20 PBS 
control and (D) 1:20 blueberry extract. Images were taken at 20x magnification using a 
Zeiss inverted fluorescent microscope. 
 
Figure 3.6 Summary data of blueberry extract nuclear condensation in NCM 356 
cell line. Quantification of Hoechst 33342 nuclear staining; all images were taken at 20x 
magnification using Zeiss inverted fluorescent microscope, n=5. 
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Figure 3.7: Phenolic rich blueberry extract greatly reduced nuclear ROS in CCD 
841 CoN cell line. CCD 841 CoN cells were treated for 24 hours with the pro-
inflammatory cytokine cocktail, followed by a 1:20 dilution of PBS or blueberry extract 
and assayed with CellROX® green nuclear ROS staining. (A) Control (B) Inflammatory 
control (C) 1:20 PBS control and (D) 1:20 blueberry extract. Images were taken at 20x 
magnification using a Zeiss inverted fluorescent microscope. 
 
Figure 3.8 Summary data of blueberry extract nuclear ROS in CCD 841 CoN. 
Quantification of CellROX® green nuclear ROS assay; all images were taken at 20x 
magnification using Zeiss inverted fluorescent microscope. *= indicates significance vs. 
non treated control, &= indicates significance vs. inflammatory control, #= indicates 
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significance vs PBS control. Results analyzed utilizing one-way ANOVA with Tukeys 
test, n=5 p<0.05. 
    
    
Figure 3.9: Phenolic rich blueberry extract greatly reduced cytoplasmic ROS in 
CCD 841 CoN cell line. CCD 841 CoN cells were treated for 24 hours with the pro-
inflammatory cytokine cocktail, followed by a 1:20 dilution of PBS or blueberry extract 
and assayed with CellROX® orange cytoplasmic ROS staining. (A) Control (B) 
Inflammatory control (C) 1:20 PBS control and (D) 1:20 blueberry extract. Images were 
taken at 20x magnification using a Zeiss inverted fluorescent microscope. 
A. B. 
C. D. 
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Figure 3.10 Summary data of blueberry extract cytoplasmic ROS in CCD 841 CoN 
cell line. Quantification of CellROX® orange cytoplasmic ROS assay; all images were 
taken at 20x magnification using Zeiss inverted fluorescent microscope. *= indicates 
significance vs. non treated control, &= indicates significance vs. inflammatory control, 
#= indicates significance vs PBS control. Results analyzed utilizing one-way ANOVA 
with Tukeys test, n=5 p<0.05. 
3.4.2 Blueberry extract significantly reduced nuclear and cytoplasmic ROS 
in inflamed colon epithelial cells based on flow cytometry analysis 
Results from fluorescent microscopy were verified utilizing CellROX® orange 
cytoplasmic and CellROX® green nuclear ROS reagent on BD Accuri™ C6 flow 
cytometer. NCM 356 treatment with 1:40 dilution of blueberry extract resulted in 
significantly reduction in nuclear generated ROS after 48 hours of treatment when 
compared to inflammatory and vehicle control groups. The cells fluorescing above 
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baseline were 33.5%, 65.8%, 60.6%, and 28.7% for non-treated control, inflammatory 
control, vehicle control and blueberry treated groups, respectively (Figure 3.11 and 3.12, 
p<0.05). Following the same conditions, blueberry extract treatment again significantly 
inhibited cytoplasmic generated ROS in NCM 356 with fluorescence above baseline of 
25.9%, 60.6%, and 23.1% for non-treated control, vehicle control and blueberry treated 
groups, respectively (Figure 3.13 and 3.14, p<0.05). When NCM 356 cells are plotted 
against both nuclear and cytoplasmic stains, drastic reductions in cellular ROS are seen in 
conjunction with previous reports (Figure 3.15) 
 The same response was observed in CCD 841 CoN, with blueberry extract 
significantly reducing both cytoplasmic and nuclear generated ROS. Nuclear generated 
ROS was reduced from, 4.9% in non-treated control, 5.6% inflammatory control, 7.9% in 
inflammatory vehicle control/PBS to 3.3% above baseline following blueberry treatment 
(Figure 3.16 and 3.17, p<0.05). Cytoplasmic ROS was again reduced from 3.7%, 4.4%, 
and 7.6% in non-treated control, inflammatory control, and inflammatory vehicle 
control/PBS, respectively to 2.5% following 48 hours treatment of 1:40 dilution of 
blueberry extract (Figure 3.18 and 3.19, p<0.05).  
    
A. B. 
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Figure 3.11: Blueberry extract decreases nuclear ROS in NCM 356 cell line as 
analyzed by flow cytometry. NCM 356 cells were analyzed for ROS with CellROX® 
green nuclear stain following 24 hour treatment with the pro inflammatory cytokine 
cocktail and an additional 48 hours with a 1:20 diulution of PBS or blueberry extract. (A) 
Control (B) Inflammatory control (C) 1:20 PBS control and (D) 1:20 blueberry extract. 
Cells were analyzed using an BD Accuri™ C6 flow cytometer.  
  
Figure 3.12: Summary data of blueberry nuclear ROS in NCM 356 as analyzed by 
flow cytometry. Quantification of CellROX® green nuclear ROS staining on NCM 356 
NCM 356 Nuc ROS Flow BB
%
  C
el
ls
Ct
l
Inf
lam
ma
tio
n
PB
S BB
0
20
40
60
80
C. D. 
#& 
* * 
106 
cell line. *= indicates significance vs. non treated control, &= indicates significance vs. 
inflammatory control, #= indicates significance vs PBS control. Results analyzed 
utilizing one way ANOVA with Tukeys test (p<0.05). 
   
  
Figure 3.13: Blueberry extract decreases cytoplasmic ROS in NCM 356 cell line as 
analyzed by flow cytometry. NCM 356 cells were analyzed for ROS with CellROX® 
orange cytoplasmic stain following 24 hour treatment with the pro inflammatory cytokine 
cocktail and an additional 48 hours with a 1:20 diulution of PBS or blueberry extract. (A) 
Control (B) 1:20 PBS control and (C) 1:20 blueberry extract. Cells were analyzed using 
an BD Accuri™ C6 flow cytometer.  
A. B. 
C. 
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Figure 3.14: Summary data of blueberry cytoplasmic ROS in NCM 356 as analyzed 
by flow cytometer. Quantification of CellROX® orange cytoplasmic ROS staining on 
NCM 356 cell line. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs PBS control. Results 
analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
 
Figure 3.15: Blueberry extract decreases nuclear and cytoplasmic ROS in NCM 356 
cell line as analyzed by flow cytometry. NCM 356 cells were analyzed with both 
CellROX® green nuclear (x-axis) and orange cytoplasmic (y-axis) stain stain following 
NCM 356 Cyto ROS Flow BB
%
  C
el
ls
Ct
l
PB
S BB
0
20
40
60
80
* 
# 
Control Inflammation Blueberry extract 
108 
24 hour treatment with the pro inflammatory cytokine cocktail and an additional 48 hours 
with a 1:20 diulution of PBS or blueberry extract. Cells were analyzed using an BD 
Accuri™ C6 flow cytometer. 
    
    
Figure 3.16: Blueberry extract decreases nuclear ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry. CCD 841 CoN cells were analyzed for ROS with 
CellROX® green nuclear stain following 24 hour treatment with the pro inflammatory 
cytokine cocktail and an additional 48 hours with a 1:20 diulution of PBS or blueberry 
extract. (A) Control (B) Inflammatory control (C) 1:20 PBS control and (D) 1:20 
A. B. 
C. D. 
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blueberry extract. Cells were analyzed using an BD Accuri™ C6 flow cytometer. 
  
Figure 3.17: Summary data of blueberry nuclear ROS in CCD 841 CoN cell line as 
analyzed by flow cytometry. Quantification of CellROX® green nuclear ROS staining 
on CCD 841 CoN cell line. *= indicates significance vs. non treated control, &= indicates 
significance vs. inflammatory control, #= indicates significance vs PBS control. Results 
analyzed utilizing one way ANOVA with Tukeys test (p<0.05). 
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Figure 3.18: Blueberry extract decreases cytoplasmic ROS in CCD 841 CoN cell line 
as analyzed by flow cytometry. CCD 841 CoN cells were analyzed for ROS with 
CellROX® orange cytoplasmic stain following 24 hour treatment with the pro 
inflammatory cytokine cocktail and an additional 48 hours with a 1:20 diulution of PBS 
or blueberry extract. (A) Control (B) Inflammatory control (C) 1:20 PBS control and (D) 
1:20 blueberry extract. Cells were analyzed using an BD Accuri™ C6 flow cytometer. 
  
Figure 3.19: Summary data of blueberry extract cytoplasmic ROS in CCD 841 CoN 
cell line as analyzed by flow cytometry. Quantification of CellROX® orange 
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cytoplasmic ROS staining on CCD 841 CoN cell line. *= indicates significance vs. non 
treated control, &= indicates significance vs. inflammatory control, #= indicates 
significance vs PBS control. Results analyzed utilizing one way ANOVA with Tukeys 
test (p<0.05). 
3.4.3 Bluberry Exract Significantly reduced cell death following treatment 
with the pro-inflammatory cytokine cocktail based on flow cytometry 
analysis 
 CCD 841 CoN cells were assayed for viability utilizing propidium iodide staining 
following treatment with the pro-inflammatory cytokine cocktail and blueberry extract. 
Non-treated control cells showed 16.5% of the population not being viable compared to 
20.5% following treatment with the pro-inflammatory cytokine cocktail, whereas 
blueberry extract treatment reduced cell death to 11.6% (Figure 3.20 and 3.21, p<0.05).  
   
A. B. 
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Figure 3.20 Blueberry extract reduced the effects of the pro-inflammatory cytokine 
cocktail on cell death in CCD 841 CoN cell line. CCD 841 CoN were treated for 24 
hours with the pro-inflammatory cytokine cocktail followed by 48 hours of a 1:20 
dilution of blueberry extract and then assayed with propidium iodide cell viability assay. 
(A) Control (B) Inflammatory control and (C) 1:40 blueberry extract. 
 
Figure 3.21: Summary data of reduced cell death by blueberry extract on CCD 841 
CoN. Quantification of propidium iodide cell viablity assay on CCD 841 CoN cell line, 
*= indicates significance vs. non treated control, &= indicates significance vs. 
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inflammatory control, #= indicates significance vs PBS control. Results analyzed 
utilizing one way ANOVA with Tukeys test (p<0.05). 
 
3.5 Discussion 
Free radicals are increasingly being associated with the occurrence and progression 
of chronic diseases in humans87. ROS generation and elimination play a critical role in 
maintenance of cellular homeostasis with high oxidative stress attributed to cancer, aging, 
and neurodegeneration36,37. ROS is produced from oxygen and includes several species 
such as superoxide and the hydroxyl radical. ROS is produced intrinsically from normal 
cellular metabolism. Additionally, it is produced from several different cell types such as 
polymorphonuclear neutrophils, as well as others involved in host-defense responses36,37. 
These species play a crucial role in regulating cellular functions, such as cell proliferation 
by oxidizing signaling proteins. Thus, these attributes make ROS very important in 
understanding processes involved in aging, inflammation and cancer.  
 Treatment of both NCM 356 and CCD 841 CoN with pro-inflammatory cytokine 
cocktail resulted in increase in both cytoplasmic and nuclear generated ROS. The 
cytokine TNF-α has been shown to induce ROS in several different cell systems, such as 
hepatocytes, rat glomeruli, HeLa and HEK 293 cells among others88-90. Additionally, a 
plethora of research suggests that both IL-1β and LPS induce ROS91-93. For example, IL-
1β was shown to increase ROS production in TMK-1 cells through IL-8 and MAP kinase 
dependent mechanisms94. LPS induced the production of ROS resulting in the activation 
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of TRAF6-ASK1-p38 signaling mechanisms, which are crucial for innate immunity in 
ASK1-deficient mice91. These studies show the role played by ROS in cell signaling 
cascades as well as various inflammatory processes. Treatment of both NCM 356 and 
CCD 841 CoN with the phenolic rich blueberry extract was able to greatly reduce nuclear 
and cytoplasmic ROS. The mechanisms by which blueberry fractions work vary in 
various cell systems. Blueberry polyphenols inhibit inflammatory responses in brain 
microglial cells by regulating several inflammatory cytokines, TNF-α, IL-1β, LPS, and 
nitric oxide95. Another study showed blueberry extract to be effective in inhibiting lipid 
peroxidation in a liposomal membrane system96. 
Several different compounds have been identified in blueberry extracts, with the 
most abundant being delphinidin, malvidin, and cyanidin, which exhibit strong anti-
inflammatory and anti-tumorigenic effects. Delphinidin is an anthocyanidin found not 
only in blueberries but also in concord grapes, cranberries, and pomegranates. 
Delphinidin acts through a wide range of pathways such as caspase activation, cell cycle 
arrest, cytokine inhibition among others97-99. Delphinidin inhibited Interleukin 1 beta (IL-
1β) induced activation of NF-κB, and COX-2 expression in human chondrocytes. IL-1β 
and NF-κB are major mediators of inflammation and disease progression97. Consumption 
of red wine extract, which included delphinidin, reduced monocyte chemo-attractant 
protein 1 (MCP-1) levels and enhanced antioxidant activity in blood plasma99. Another 
study found that the combination of cyanidin, malvidin, peonidin, petunidin and 
delphinidin suppressed the growth of aggressive non-small-cell lung cancer with very 
little effect on  normal cells by inducing cell cycle arrest and apoptosis mediated by 
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oncogenic notch and WNT pathways as well as their downstream targets100. Delphinidin 
also showed positive results with regards to inflammation of human airway epithelial 
cells (NCI-H292)98. Another study found delphinidin to induce apoptosis in human colon 
carcinoma cells (HCT116) and human leukemia cells (HL60)101. Delphinidin was shown 
to downregulate the expression of matrix metalloproteinase 9  in MCF-7 human breast 
cancer cell line following inflammatory induction by phorbol 12-myristate 13-acetate102. 
This metalloproteinase has a role in metastasis mediated through NF-κB.  
 Malvidin is another anthocyanidin found in berries, such as blueberries and 
cranberries. It also exhibits antioxidants, chemo-preventative, and cardio protective 
properties103. Malvidin drastically decreased the expression of TNF-α, IL1, IL-6 and 
iNOS in human peripheral blood mononuclear cells (PBMC)104. Macrophages stimulated 
by bacterial LPS, when treated with malvidin, decreased expression of NF-κB and ROS 
production and upregulated levels of Akt and MAPK phosphatase-1105. 
 Cyanidin, more specifically, cyanidin-3-O-β-D-glucoside (C3G) is a water-
soluble anthocyanin pigment with antioxidant, anti-carcinogenic, and anti-inflammatory 
properties106,107. For example, in human THP-1 cells, C3G inhibited the expression of IL-
6 and TNF-α in LPS stimulated inflammatory model107. Additionally, C3G showed 
strong anti-inflammatory properties in HT-29 cell line treated with a pro-inflammatory 
cytokine cocktail consisting of IL-1α, TNF-α, and IFN-γ which reduced the expression of 
NO, PGE2, IL-8, iNOS, and COX-2 at lower concentrations than the NSAID, 5-
aminosalicyclic acid108. This study suggests that anthocyanins have the ability to reach 
the gastrointestinal tract and exhibit potent anti-inflammatory effects108. C3G inhibited 
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UVB-induced skin damage in mice by reducing glutathione depletion and lipid 
peroxidation as well as IL-6, and TNF-α, which are associated with inflammatory 
processes109.  
 The anti-inflammatory effects, based on decrease in ROS, in cell lines treated 
with blueberry extract is likely due to the anthocyanidins present in blueberry extract. 
Furthermore, our research group examined the comparative effects of novel rice callus 
suspension culture (RCSC) against blueberry extract in free radical scavenging 
capabilities. In comparing the two, blueberry extract was greatly more efficient at 
decreasing nuclear and cytoplasmic ROS versus RCSC. However, RCSC was better at 
preventing cytokine induced cell death as analyzed by flow cytometry with propidium 
iodide staining. Furthermore, while a plethora of literature exists on the benefits of 
maintenance of ROS, in general decreases have shown to be beneficial to cell systems.  
 Increases in nuclear and cytoplasmic ROS could be a beneficial response to the 
pro-inflammatory cytokines by disrupting cell-signaling pathways that trigger cell death 
through oxidation of key molecular targets, thus increasing cell viability. This was seen 
following treatment with RCSC. On the other hand, since the pro-inflammatory cytokine 
cocktail increases oxidative stress, a mechanism that often leads to cell death, decreasing 
oxidative stress by blueberry extract could additionally be a mechanism of survival. 
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3.6 Conclusion and future work 
  Blueberry extract exhibited strong anti-inflammatory and anti-oxidant capabilities 
following treatments of two colon epithelial cell lines with a pro-inflammatory cytokine 
cocktail followed by cytoplasmic and nuclear ROS assays. These results align with 
previous research as well as the importance of consuming antioxidant rich foods. While 
several compounds have been identified in blueberry extracts, only a few are described 
above. Some of these compounds have been implicated as possible drug candidates for 
inflammatory conditions such as IBD where maintenance of redox homeostasis is of 
crucial importance. Further research is needed to fully understand their effects in vivo. 
Development of blueberry callus suspension culture and its use as an anti-inflammatory 
agent is another area of future research. If blueberry callus suspension culture works as a 
better anti-inflammatory agent than blueberry extract, novel drugs can be developed with 
little or no side effects. The chemical constituents of blueberry callus suspension culture 
can be identified and compared with that of blueberry extract and the biochemical 
pathways and molecular mechanisms employed need to be investigated.  
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Conclusion 
It has been previously reported that RCSC exhibits potent anticancer properties on 
multiple cell lines. For the first time, we have reported RCSC also functions as a potent 
anti-inflammatory and immune regulating agent on an in vitro inflammatory bowel 
disease model. RCSC was able to strongly regulate reactive oxygen species (ROS) 
signaling as well as prevent cytokine induced cell death. Additionally, several changes in 
gene expression were identified versus both the inflammatory and plant medium control. 
Specifically, NF-κB and SKI were up regulated, while CCL5, CD38, HLA1, and IKBKB 
were down regulated in NCM356. In CCD 841 CoN, CSF-2, GNLY, IL-1A, IL-1B, IL-6, 
IL-8, LIF, and PTGS2 were up regulated, and CSF-1, CXCL10, FAS, LY96, NFATC3, 
and SMAD3 were down regulated. 
Extract of highbush blueberries were able to strongly regulate reactive oxygen 
species. In both NCM 356 and CCD 841 CoN, nuclear and cytoplasmic ROS were 
greatly reduced versus inflammatory control. Fluorescent microscopy analysis of nuclei 
in both cell lines showed less nuclear condensation versus inflammatory control as well. 
Flow cytometry analysis of CCD 841 CoN revealed a significant reduction in cell death 
in blueberry treated groups following treatment with the pro-inflammatory cytokine 
cocktail. 
 RCSC was further analyzed for anticancer activity via fluorescent microscopy and 
flow cytometry using propidium iodide staining. RCSC acted as an efficient anticancer 
agent on SW620 in a dose dependent manner as previously reported. A dose response 
curve showed EC50 dilution factor to be 3.64. Furthermore, toxicity was assessed in vitro 
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on the normal colon cell line CCD 841 CoN. Roughly a 10-fold reduction, to 4.38 with 
the EC50 dilution factor, was observed.  
A total of 25 fractions were collected via column chromatography in order to identify 
the bioactive constituents in RCSC. Fractions 10-18 had similar HPLC peaks, and eight 
individual peaks were identified in the pooled fractions. Peak number 6, was UV excited, 
which indicates possible conjugation with active functional groups, was poorly soluble in 
water, further indicating possible hydrophobic functional groups. RCSC fractions 10-18, 
when tested for anticancer activity in vitro on the colon adenocarcinoma cell line SW620, 
resulted in a similar response on cell death compared to whole RCSC. Toxicity was again 
assessed on the normal colon cell line CCD 841 CoN by flow cytometry with propidium 
iodide staining and resulted in a similar, but slightly mitigated response compared to 
whole RCSC. Regulation of ROS by fractions 10-18 was similar in response to whole 
RCSC as well. In conclusion, RCSC acts as a potent anti-inflammatory and immune 
regulating agent. Moreover, highbush blueberry extract exhibited potent free radical 
scavenging capabilities. Lastly, RCSC fractions 10-18 are likely responsible for the 
anticancer, anti-inflammatory, and immune regulating functions of whole RCSC. 
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Future Directions 
Isolation and characterization of the compounds responsible for the effects of RCSC 
observed in the current study need to be identified. While recent published and 
unpublished work has indicated potent anti-cancer, anti-inflammatory, and immune 
regulating activity in RCSC, more research is needed to fully understand the biochemical 
and molecular mechanisms, specifically, in vivo testing in an animal model. 
Metabolomic, transcriptomic and proteomic analysis of inflamed cells treated with RCSC 
will lead to the identification of gene networks, protein-protein interactions and 
biological pathways involved in the process. Furthermore, docking studies involving 
differentially regulated metabolites and proteins will identify possible drug candidates, 
which can be used for further testing. This work and work of others has set the 
foundation for a novel method of in vitro generation of bioactive compounds with potent 
anticancer, anti-inflammatory, and immune regulating properties. While much work is 
still needed, this dissertation further outlines the beneficial role of secondary metabolites 
in rice callus suspension culture for human health. 
